Equine obesity-related hyperleptinemia by Huff, Nan Killen
Louisiana State University
LSU Digital Commons




Louisiana State University and Agricultural and Mechanical College
Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_dissertations
Part of the Animal Sciences Commons
This Dissertation is brought to you for free and open access by the Graduate School at LSU Digital Commons. It has been accepted for inclusion in
LSU Doctoral Dissertations by an authorized graduate school editor of LSU Digital Commons. For more information, please contactgradetd@lsu.edu.
Recommended Citation












Submitted to the Graduate Faculty of the 
Louisiana State University and 
Agricultural and Mechanical College 
in partial fulfillment of the 
requirements for the degree of  




The Interdepartmental Program in  










Nan Killen Huff 
B.S., Louisiana State University, 1979 





“We must believe in ourselves or no one else will believe in us;  
we must match our aspirations with  
the competence, courage and determination to succeed.” 
Rosalyn Sussman Yalow 
 So many professors, family, and friends have encouraged me along my personal and 
academic journey.  I am extremely grateful for all of the local and long-distance support I have 
received while researching and writing this dissertation. Firstly, I want to thank my doctoral 
advisor, Dr. Donald L. Thompson, Jr., for his supervision and direction.  Secondly, I want to 
thank the professors who served on my Doctoral Committee: Dr. Kenneth R. Bondioli, Dr. 
Robert A. Godke, Dr. Dale L. Paccamonti, Dr. Cathleen C. Williams, and Dr. Tin-Wein Yu, for 
good teaching and intellectual challenge. Thirdly, I want to thank Dr. Laura Gentry for her 
immense help, encouragement, and advice.  
I have also received significant emotional support and advice from my fellow graduate 
students Bill Storer, Josh Cartmill, Pam Mitcham, Kristian Kelly, Cara Waller, and Maxon 
Graham.  On many occasions, each of them offered the brilliant idea, the helpful suggestion, or 
the coldest beer.  All members of my work family at the LSU School of Veterinary Medicine 
have also been exceptionally supportive and encouraging.  A special thank-you to Leslie Talley, 
Claudette Leake, Catherine Koch, Frank Garza, Dr. Ashley Stokes, Mike Keowen, Dr. Rustin 
Moore, Dr. Susan Eades, and Dr. Britta Leise. 
My husband, Jim, has unwavering faith in me. He has carried more than half the burden 
in terms of his emotional support, and I cannot thank him enough for the encouragement that he 
has given me. Our daughter, Jimmie, has always believed in me and has been remarkably 
tolerant of my absence. Three generations of family have supported me throughout my doctoral 




ACKNOWLEDGMENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . i i
LIST OF TABLES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . v
LIST OF FIGURES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . vi
ABSTRACT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . viii
CHAPTER
1 INTRODUCTION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
2 REVIEW OF LITERATURE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
Discovery of the Leptin Gene . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
Molecular Organization of the Leptin Gene and Receptor . . . . . . . . . . . . 7
Receptor Pathways . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
Diurnal Profile . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
Leptin and Nutrition . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
The Hypothalamic-Pituitary-Gonadal Axis . . . . . . . . . . . . . . . . . . . . . . 18
The Hypothalamic-Pituitary-Adrenal Axis . . . . . . . . . . . . . . . . . . . . . . . 26
Leptin and the Immune System . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
3 BREEDING OUTCOME OF LACTATING MARES WITH HIGH
VS. LOW PLASMA LEPTIN CONCENTRATIONS . . . . . . . . . . . . . . . . . . . . 41
Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
Materials and Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43
Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46
Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52
4 SEARCH FOR POLYMORPHISM IN EXON 2 OF THE EQUINE
LEPTIN GENE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60
Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60
Materials and Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 61
Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 68
Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 72
 
iv
5 ENDOCRINE RESPONSES TO ADMINISTRATION OF A 
LOW DOSE OF ENDOTOXIN LIPOPOLYSACCHARIDE 
IN MARES AND GELDINGS WITH HIGH VS. LOW PLASMA 
LEPTIN CONCENTRATIONS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 78
Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 78
Materials and Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 79
Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 82
Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 92
6 SUMMARY AND CONCLUSIONS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98
REFERENCES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 100
VITA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 115
vLIST OF TABLES
Table
3.1  Breed prevalence, feeding regimen, mean mare and foal ages, mean 
body condition scores, and mean leptin concentrations for mares on the 
eight farms throughout Louisiana in Experiment 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
4.1  Comparison of equine nucleotide sequence . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 72
5.1  Sources of variation in the ANOVA and associated P-values for each 
        hematologic variable in the 24-h sampling period . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 86
 
5.2  Sources of variation in the ANOVA and associated P-values for each 




3.1 Leptin in the two morning blood samples 1 vs. 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47
3.2 Frequency diagram for mean leptin concentration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47
3.3 Frequency diagram for body condition score . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
3.4 Leptin as a function of body condition score . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49
3.5 Feeding regimen affected leptin levels . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49
3.6 Farm was a significant source of variation for leptin concentrations (P<0.0001) . . . . . . 50
3.7 Percentage of mares pregnant at the end of the breeding season . . . . . . . . . . . . . . . . . . . 50
3.8 Leptin samples 1 vs. 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
3.9 Body condition scores for non-lactating mares relative to leptin levels . . . . . . . . . . . . . 52
4.1 Equine leptin mRNA (GenBank AY462242) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65
4.2 Forward and reverse sequencing primers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67
4.3 Relationship between serum leptin concentrations and BCS . . . . . . . . . . . . . . . . . . . . . 68
4.4 Leptin concentrations in mares, stallions and geldings . . . . . . . . . . . . . . . . . . . . . . . . . . 69
4.5 Exon 2 with partial sequence of flanking introns . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70
5.1 Mean total blood leukocyte counts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 82
5.2 Mean total blood lymphocytes counts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 83
vii
5.3 Mean total blood neutrophil counts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 84
5.4 Mean total platelet counts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 84
5.5 Mean packed cell volume . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85
5.6 Mean total protein . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 86
5.7 Mean heart rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87
5.8 Mean respiratory rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 88
5.9 Mean rectal temperature . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 88
5.10  Resting concentrations of insulin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 89
5.11 Mean concentrations of cortisol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90
5.12 Mean concentrations of GH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90
5.13 Mean concentrations of prolactin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 91




Plasma leptin concentrations in obese adult horses have been shown to vary widely, and 
horses tend to fit into two groups: low leptin (<10 ng/mL) and hyperleptinemic (10 to 50 ng/mL).   
Observations over time revealed that the hyperleptinemic condition was consistent, possibly 
indicating a relatively permanent underlying cause.  Based on these observations, three 
experimental approaches were used to further study equine obesity-related hyperleptinemia.  The 
first experiment determined the prevalence of hyperleptinemia among postpartum, lactating 
mares, evaluated its consequence on their re-breeding success, and investigated correlations 
between leptin levels in lactating and non-lactating mares.  Postpartum mares (n = 198) and non-
foaling mares (n = 31) were categorized based on their leptin status: normoleptinemic or 
hyperleptinemic.  Leptin in the lactating mares averaged 4.8 ng/mL, and 11 of the 198 (13%) 
displayed hyperleptinemia.  Leptin in the non-lactating mares averaged 7.5 ng/mL, with 9 mares 
(29%) displaying hyperleptinemia.  Of the 198 lactating mares bred, 81% became pregnant; there 
was no effect of leptin status on re-breeding success.  To study one possible cause for 
hyperleptinemia in well-fed horses, a second experiment explored polymorphism(s) within exon 
2 of the equine leptin gene.  The DNA from five hyperleptinemic and five normal mares of high 
body condition was used to analyze exon 2 of the leptin gene for polymorphisms.  Based on the 
10 mares tested, there was no polymorphism in exon 2 of the equine leptin gene; therefore, 
polymorphism is not a likely explanation for the high vs. low leptin difference.  The third 
experiment explored the possible effects of hyperleptinemia on the endocrine and immune 
systems.  Endotoxin was given to mares and geldings to investigate the role and/or regulation of 
leptin in the pro-inflammatory cytokine response.  Of the endpoints measured, only platelet 
count differed between normal and hyperleptinemic horses.  Endotoxin infusion caused the 
 ix
expected pro-inflammatory cytokine and endocrine responses, but leptin status was not a 
significant factor for any endpoint.  It is concluded that hyperleptinemia in mares is not 
associated with polymorphism in exon 2 of the leptin gene, does not affect re-breeding rates of 
foaling mares, and does not alter the endotoxin-induced responses of the endocrine and immune 
systems. 
 




Human obesity has become a widespread nutritional disorder in the United States.  
Moreover, increased body weight is associated with type II diabetes, hypertension, 
hyperlipidemia, and certain cancers.  Although obesity is often considered to be a psychological 
problem, there is increasing evidence that body weight is physiologically regulated (Zhang et al., 
1994).  Equine obesity has become a common nutritional and financial concern for horse owners.  
In the past, horses were able to continuously graze on native grasses and forage in a manner that 
efficiently stored fat in the summer months.  This resourceful storage of energy would sustain the 
horse through the leaner months of scarce forage (Johnson, 2004).  Today, forage is rarely 
scarce, even for pastured horses.  Furthermore, many horses are stalled and grain-fed twice daily, 
with unlimited hay and water.  As a result, the modern horse continuously stores fat throughout 
the year.   
 Proper regulation of feed intake is important for optimizing growth, performance, 
reproduction, lactation, and overall health in the equine species.  The present problem of 
overfeeding horses generally contributes to numerous clinical disorders, including 
hyperleptinemia, hyperinsulinemia, hyperglycemia, the metabolic syndrome, and laminitis.  
Therefore, investigation into the basic systems that regulate adiposity, as well as the interactions 
between those systems, may lead to new knowledge that will further enhance equine 
performance and health. 
 Leptin, a 16-kDa protein, has been reported to be primarily derived from adipose tissue, 
thus circulating concentrations are generally correlated to body fat mass in animal species and 
humans (Prolo et al., 1998; Chilliard et al., 2000).  Similar results have been reported for the 
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horse, in which body fat mass was estimated by ultrasonography of backfat (Fitzgerald and 
McManus, 2000) or visually by body condition score (BCS; Buff et al., 2002; Gentry et al., 
2002).  Additionally, Gentry et al. (2002) reported that leptin concentrations in adult mares with 
high BCS in September varied widely, and mares tended to fit into two distinct groups based on 
leptin concentrations: low (<5 ng/mL) or high (7 to 20 ng/mL).  Subsequent observations of 18 
of those mares indicated that the high versus low distinction was consistently observed 2 yr later, 
indicating that the underlying cause was likely permanent (Cartmill et al., 2003).   
 Leptin secretion by adipocytes has been reported to be affected by various other 
hormones, including insulin (Sivitz et al., 1998; Ramsay and White, 2000), growth hormone 
(Isozaki et al., 1999), glucocorticoids (Cartmill et al., 2003), epinephrine (Cammisotto and 
Bukowiecki, 2002), prolactin (Mastronardi et al., 2000), and thyroid hormones (Cartmill et al., 
2003).  In addition to having a role in endocrine function, leptin also regulates immune functions.  
Research by Faggioni et al. (1998, 2001) indicated that leptin levels are increased by pro-
inflammatory cytokines, such as IL-1, TNF-α, and IL-6.   Leptin levels increase acutely during 
infection and inflammation, and may represent a protective component of the host response to 
inflammation. 
 This dissertation sought to improve on the knowledge of the physiologic and genetic 
differences between horses in good body condition that are hyperleptinemic vs. those with 
normal plasma leptin concentrations.  The first objective was to investigate the occurrence of 
high leptin mares and the effect of high plasma leptin levels on fertility.  In a low leptin 
environment, GnRH release is decreased, possibly to prevent energy being wasted for 
reproduction (Caprio et al., 2001).  Research conducted by Gentry et al. (2002) revealed that low 
BCS and leptin concentrations were associated with inactive ovaries during winter and early 
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spring, although the mares with low BCS did eventually ovulate.  In contrast, hyperleptinemia 
can interfere with gonadotropin stimulation of peripheral targets.  Spicer (2001) concluded that 
in a high leptin environment, the ovary is kept from overproducing estradiol via leptin inhibition 
of insulin-induced steroidogenesis.  Given the possibility that different concentrations of leptin 
exert both inhibitory and stimulatory actions on the hypothalamic-hypophyseal-gonadal axis, the 
first investigation was designed to determine any effect of leptin level on the re-breeding 
capabilities of high versus low leptin mares (as described by Cartmill et al., 2003), as well as to 
examine the relative leptin concentrations in lactating and non-lactating mares. 
The second objective was to consider the occurrence of polymorphisms in the equine 
leptin gene.  The wide variation in leptin values in well-fed horses indicated that some other 
factor besides body condition affects leptin concentrations in obese horses.  Animal studies have 
shown that polymorphisms associated with fatness exist within the leptin gene.  An allelic 
variation within exon 2 of the leptin gene is associated with increased fat deposition in beef cattle 
and increased milk output in dairy cattle (Buchanan et al., 2002, 2003).  The second experiment 
was designed to investigate the possible occurrence of an analogous single nucleotide 
polymorphism in exon 2 of the equine leptin gene.   
The third objective was to further consider the high leptin versus low leptin condition, 
and the interaction of leptin secretion between the endocrine and immune systems.  Using the 
resident herd of horses with high and low plasma leptin concentrations, a slow-infusion, low 
dose of endotoxin was administered to the horses in order to measure the endocrine response.  
Hormones measured were leptin, insulin, cortisol, prolactin, and growth hormone; the cytokines 
measured were TNF-α and  IL-6. 
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CHAPTER 2 
REVIEW OF LITERATURE 
Discovery of the Leptin Gene 
 During the summer of 1949, Ann Ingalls made an astounding discovery at the Jackson 
Laboratory in Bar Harbor, Maine.  Ingalls came across some plump, young mice in the research 
breeding stock of Jackson Laboratory mice on the C57BK/6J background.  This early obese 
model, later designated the ob/ob mouse, was observed to gain weight rapidly until the animal 
was about four times the weight of normal animals.  The recessive ob gene was also discovered 
to cause sterility in the homozygote (Ingalls et al., 1950).  A db (diabetes) mouse was later 
discovered on the C57BL/KsJ background.  The db mouse model was similarly obese, but also 
hyperglycemic (Hummel et al., 1966).  Recessive mutations in the ob and db genes were found 
to result in obesity and diabetes in a syndrome resembling morbid obesity; ob/ob and db/db mice 
have identical phenotypes, each weighing three to four times more than normal mice (Friedman 
and Halaas, 1998). 
 The concept of a biological factor in weight regulation has been researched and reviewed 
for decades.  In 1840, a clinician by the name of Mohr gave the first detailed description of 
hypothalamic obesity.  Mohr’s patient displayed a rapid weight gain, and upon autopsy, Mohr 
found that a tumor had invaded the pituitary gland and hypothalamus.  One hundred years later, 
Hetherington and Ranson (1942) identified the hypothalamus as a principal site in the regulation 
of body weight.  The research team lesioned the ventromedial hypothalamus (VMH) in the 
laboratory rats without damaging the rat’s pituitary.  Subsequently, the lesioned laboratory rats 
developed hyperphagia and obesity (Hetherington and Ranson, 1942).  Anand and Brobeck 
(1951) suggested that the hypothalamus contained nervous centers which normally control the 
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intake of food, and that these centers are damaged by hypothalamic lesions.  Early research 
suggested that bilateral lesions in the region of the VMH cause obesity when the animal has free 
access to palatable food (Hervey, 1959).  Of the brain regions implicated in the regulation of 
feeding behavior, the VMH is considered to be the most important satiety center in the central 
nervous system (Zhang et al., 1994).   
Over the next decade, three theories were introduced to explain a feedback system in 
relation to the control of an animal’s food intake.  The first theory, postulated by Brobeck 
(1948), proposed that a rise in temperature after eating is the signal for cessation of eating; 
therefore, regulated feeding is part of body temperature control.  Brobeck summarized his 
hypothesis as “animals eat to keep warm, and stop eating to prevent hyperthermia.”  Mayer 
(1952) proposed the “glucose theory,” suggesting that the difference between the arterial and 
venous blood levels of glucose represents the key factor in the feedback system for appetite 
control.  Kennedy (1953) suggested that adjustment of feeding is made in relation to the amount 
of stored fat in the body.  Kennedy’s “lipostasis theory” proposed that there was a product of 
adipose tissue that circulated in the blood and acted as a feedback signal to the hypothalamus.  
As fat accumulates, appetite is depressed; when fat stores fall below a critical threshold, appetite 
is increased. 
The lipostatic theory was later supported by an experiment carried out by Hervey (1959).  
Hervey investigated the mechanism and pathways by which normal animals regulate their food 
intake over long periods and thus maintain energy balance.  Hervey performed a series of 
parabiotic experiments on rats at the University of Cambridge, surgically joining rodents that 
displayed bilateral lesions of the ventromedial nucleus with rodents that had an intact VMH.  In 
the conjoined circulatory systems, the animal with a damaged hypothalamus rapidly became 
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obviously obese as a result of hyperphagia, while intact control animals lost body weight due to 
decreased food intake.  Hervey suggested that the partner with a normal hypothalamus became 
thin because the animal ate less.  This result was due to a response on the part of the 
hypothalamic controlling centers to overfeeding by the operated animals.  Hervey’s classic 
parabiotic experiments supported Kennedy’s lipostasis theory, but the assumed satiety factor still 
remained unknown (Henson and Castracane, 2003).   
 Coleman (1973), in his notable parabiosis studies, provided evidence that such a 
circulating signal exists.  Several decades after Ingall’s obese mouse discovery, Coleman (1973) 
conducted parabiotic studies with ob/ob and db/db mice at the Jackson Laboratory.  Both the 
obesity and diabetic syndromes are characterized by hyperphagia, obesity, hyperglycemia and 
hyperinsulinemia.  Parabiosis of ob/ob with db/db mice caused the obese partner to become 
hypoglycemic, to lose weight, and to die of starvation, once tissue reserves were exhausted.  No 
abnormal changes were observed in the diabetic partner.  Coleman (1973) postulated that the 
ob/ob mouse is unable to produce sufficient satiety factor to regulate its food consumption, 
whereas the db/db mouse produces a satiety factor, yet cannot respond to it due to a defective 
satiety center.  The data from the parabiosis experiments suggested that the db gene encoded for, 
and was therefore was responsible for, the production of a circulating factor that regulated 
energy balance.  The finding was that the ob gene encoded the receptor for this factor. 
 A team led by Jeffrey Friedman at Rockefeller University published the specific gene 
defect of ob/ob mice in December of 1994 (Zhang et al., 1994), after an eight-year search.  The 
ob gene, isolated by positional cloning, was found to encode a 167-amino acid secreted protein, 
including a 21 amino acid secretory sequence.  The name of the hormone, leptin, was taken from  
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the Greek leptos, meaning thin or lean, and was descriptive of the body weight-reducing quality 
of the hormone (Henson and Castracane, 2003).   
A nonsense mutation in codon 105 of the leptin gene was found in the original C57BL/6J 
ob/ob mouse strain.  In the ob/ob mouse, a mutation in the leptin gene results in a premature stop 
codon at position 105, which results in leptin deficiency, hyperphagia, and obesity (Boute et al., 
2004).  The increased level of ob RNA in the C57BL/6J mutant, which has greatly increased fat 
cell mass, raised the possibility that the level of expression of the ob gene signals the size of the 
adipose depot (Houseknecht et al., 1998).   
 Although leptin is mainly produced and secreted by white adipocytes, this is not the only 
potential source of the hormone.  Placenta, gastric mucosa, bone marrow, mammary epithelium, 
skeletal muscle, pituitary, hypothalamus, and bone have also been shown to produce small 
amounts of leptin in certain circumstances (Frühbeck, 2006).  Circulating leptin may be found in 
free form or complexed with leptin-binding proteins.  The half-life of free leptin is about 30 
minutes, with the kidneys being responsible for approximately 80% of leptin clearance from the 
peripheral circulation (Henson and Castracane, 2003).   
Molecular Organization of the Leptin Gene and Receptor  
The leptin gene consists of three exons, which are separated by two introns.  The first 
exon is not transcribed into the leptin protein.  The first 21 amino acids of the leptin gene 
function as a signal peptide, and are cleaved off before the 146 amino acid protein is released 
into the blood as a circulating protein (Zhang et al., 1997).  Leptin has a 67% sequence identity 
among the humans, gorillas, chimpanzees, orangutans, rhesus monkeys, dogs, cows, pigs, rats, 
and mice.  Leptin shares many structural similarities to other helical cytokines, including IL-6 
and growth hormone (Henson and Castracane, 2003). 
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 Modeling of the leptin structure is difficult as the wild type aggregates extensively in 
vitro, so it cannot readily be crystallized.  Zhang et al. (1997) substituted glutamine for 
tryptophan at position 100, which resulted in a protein (E-100) with comparable biological 
activity.  The leptin E-100 mutation was crystallized to determine the molecular structure.  The 
leptin protein is an elongated molecule with approximate dimensions of 20 x 25 x 45 Å.  Leptin 
consists of four anti-parallel α-helices (A, B, C, and D), connected by two long crossover loops 
(AB and CD) and one short loop (BC), arranged in a left-handed, twisted, helical bundle.  The 
four-helix bundle takes an unusual up-up-down-down fold, which forms a two-layer packing of 
anti-parallel helix pairs A and D against B and C.  A large, hydrophobic, cylindrical core, 
parallel to the helical bundle axis, is formed from the mostly conserved residues of the four α-
helices that face one another (Zhang et al., 1997).    
An interesting feature of leptin is the small, helical, segment E, found in the CD loop and 
packed tightly against the helical bundle.  The E helix is distorted, bending sharply in the middle, 
and almost perpendicular (87 degrees) to the helix bundle.  Helix E serves as a hydrophobic cap 
to bury the lipophilic residues on the surface of the BD helical bundle (Zhang et al., 1997). 
An intrachain disulfide bond maintains stability of the native state folded protein, and is 
essential for bioactivity.  Although disulfide bonding patterns are not highly conserved within the 
cytokine family, it seems that leptin’s single disulfide bridge is critical for the development of its 
helical cytokine folding.  The leptin protein contains two cysteine residues, Cys 96 and Cys 146, 
which form a disulfide bond between the C-terminus of the protein and the beginning of the CD 
loop.  Since the disulfide bond is exposed to solvent at one end, it moves the last turn of the D 
helix 36 degrees towards the CD loop, causing a kink in the D helix.  The distinctive kink may 
serve to maximize the close contact area between the helices in the structure.  Both of the 
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cysteines in leptin are conserved among species.  Mutation of either renders the protein 
biologically inactive, indicating that the disulfide bridge and the kink in the D helix are essential 
for proper folding and receptor binding (Zhang et al., 1997).  In ob/ob mice, this intrachain 
disulfide bond cannot be formed, due to the appearance of a premature stop codon at position 
105 (Boute et al., 2004).  Research conducted by Boute et al. (2004) demonstrated that lack of 
the disulfide bond is sufficient to impair leptin secretion, because that lack results in 
accumulation of macromolecular aggregates in the cell. 
 The crystal structure of leptin-E100 suggests that leptin may be classified in the long-
chain, helical, cytokine family, inclusive of IL-6, IL-11, and IL-12.  Although the information 
about leptin’s structure places it in the long-chain, helical, cytokine category, several 
distinguishing characteristics of leptin remain that fall into no category.  Other long-chain, 
helical cytokines have extra helices in the AB loop, whereas leptin has a distorted E helix in the 
CD loop.  For example, Helix B in other cytokines is two turns longer than that of leptin; 
furthermore, other helices in cytokines have kinks in the middle, rather than at the end, similar to 
leptin.  Understanding these differences and the other distinguishing characteristics of leptin 
provides insight into its specific function (Zhang et al., 1997). 
  Leptin Receptor.  Parabiosis studies with ob/ob and db/db mice indicated that db/db mice 
were defective in reception of the ob gene product signal (Coleman, 1973).  Later studies by 
Tartaglia et al. (1995) led to the identification of the leptin receptor from mouse choroid plexus, 
using an expression-cloning strategy.   In the db/db mouse, the mRNA for the long form of the 
receptor is abnormal and yields a receptor with a truncated, intracellular domain that is unable to 
appropriately signal, thus confirming the prediction made by Coleman, based upon his classic 
parabiosis studies (Houseknecht et al., 1998). 
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 The leptin receptor (OB-R), is a member of the class I cytokine receptor superfamily, 
and is closely related to: a) gp130, the signal-transducing membrane protein of the IL-6 signaling 
complex, b) the leukemia inhibitory factor (LIF) receptor, and c) the granulocyte colony-
stimulating factor (G-CSF) receptor (Tartaglia et al., 1995).  Members of this family have 
characteristic extracellular motifs of four cysteine residues and two highly conserved cytokine 
domains with the sequence motif of WSXWS (Trp-Ser-Xaa-Trp-Ser), containing a different 
number of fibronectin type III domains (Frühbeck, 2006). 
Leptin acts through its receptor, which has six isoforms.  The OB-R is a glycoprotein 
with a single transmembrane-spanning region (Tartaglia, 1997).  All isoforms share an identical 
extracellular ligand-binding domain, with the characteristic motif of four cysteine residues and 
WSXWS.  Five isoforms possess transmembrane and cytoplasmic regions; one is a circulating, 
soluble isoform.   
The soluble leptin receptor circulates in the blood and can bind leptin with a high affinity.  
Thus, it plays a role in regulating the plasma levels of free leptin, the biologically active form.  In 
obese individuals, soluble receptor levels are reduced, whereas the receptor is up-regulated in 
emaciation (Hegyi et al., 2004).   
The membrane bound isoforms consist of a triad of distinct domains: a) an extracellular, 
leptin binding domain, b) a transmembrane domain, and c) an intracellular, cytoplasmic tail 
(Henson and Castracane, 2003).  The transmembrane and proximal 29 intracellular amino acid 
residues, including an intracellular proline-rich “box1” motif, are the same in all forms.  The 
intracellular, cytoplasmic domain of the leptin receptor varies in length with each isoform.  
Membrane bound isoforms originate from a single mRNA transcript and are produced as a result 
of alternative splicing.  Amino acid 29 of the intracellular domain provides the point of 
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divergence.  The OB-Rb form contains about 303 intracellular amino acids, whereas the short 
forms OB-Ra, OB-Rc and OB-Rd have 34, 32, and 40 amino acids, respectively (Henson and 
Castracane, 2003).   
The leptin receptor is present in many tissues.  In fact, there are very few tissues that do 
not express mRNA for at least one isoform of the leptin receptor.  This would indicate that many 
tissues and organs are primed for leptin action, and that the polypeptide may exert physiological 
influences via paracrine mechanisms.  However, the hypothalamus constitutes a high expression 
of OB-Rb (Henson and Castracane, 2003; Frühbeck, 2006).   
Since only the long form (OB-Rb) has both the box1 and box2 motifs, as well as three 
intracellular tyrosine residues, this seems to be the functional signaling isoform (Tartaglia, 1997; 
Henson and Castracane, 2003; Hegyi et al., 2004), and is thought to be responsible for the central 
actions of leptin (Tartaglia et al., 1995).  Tyrosine residues are located at positions 985, 1077, 
and 1138, and are conserved among known species of long-form leptin receptors (Bjørbæk et al., 
2001).  The OB-Ra form is present at the blood brain barrier (BBB), with the highest levels in 
the choroid plexus and in microvessels of the BBB (Tartaglia et al., 1995; Frühbeck, 2006).  
Research has shown that leptin enters the brain by a specific mechanism, independent of insulin 
(Banks et al., 2000), and it seems that OB-Ra plays a modulating role in transporting leptin 
across the BBB (Tartaglia et al., 1995; Banks et al., 2000).  The OB-Rc form was found in brain 
tissues taken from cortex and cerebellum.  This indicates that OB-Rc might also function as a 
leptin transporter in the brain, as either a different or additional function to OB-Ra.  The OB-Re 
form, a circulating and soluble receptor, lacks the transmembrane and cytoplasmic parts, and 
therefore functions as a binding protein for leptin.  A change in OB-Re levels regulate, in part, 
the biological activity of leptin in the circulation (Frühbeck, 2006).   
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Receptor Pathways 
A complex network of interacting signaling pathways appears to regulate food intake, 
fuel balance, and body weight.  Leptin receptors, members of the class I cytokine receptor 
superfamily, do not have activity inside the cell; therefore, the leptin receptor does not have 
endogenous kinase activity.  Cell-based in vitro studies and in vivo experiments have led to a 
relatively detailed understanding of intracellular signaling regulation by the leptin receptor.  Four 
important and different pathways include JAK/STAT, MAPK, PI-3K, and AMPK (Bjørbæk and 
Kahn, 2004). 
 JAK/STAT.  Early recognition of OB-R as a member of the cytokine receptor superfamily 
resulted in the prompt identification of the JAK/STAT pathway as one of the main signaling 
cascades activated by leptin (Hegyi et al., 2004; Frühbeck, 2006).  Leptin signaling via the 
JAK/STAT pathway has been well documented and is associated largely with the OB-Rb 
isoform (Tartaglia, 1997; Houseknecht et al., 1998).   
 The JAK/STAT pathway consists of four non-receptor tyrosine kinases (JAK) and seven 
85 to 95 kDa transcription factors (STAT) that are regulated by phosphorylation on specific 
serine and tyrosine residues (Frühbeck, 2006).  The pathway enables the leptin hormonal signals, 
which are not fat soluble, to penetrate the cell membrane and be delivered to the cell nucleus to 
affect gene expression.  The JAK/STAT is a simple pathway with two major players: janus 
kinase, a family of intracellular tyrosine kinases; and signal transducers and activators of 
transcription proteins.  The STAT proteins are initially present in inactive forms in the 
cytoplasm, while JAK are constitutively associated with the cytoplasmic membrane-proximal 
regions of various receptors (Frühbeck, 2006).   
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Of the four known members of the JAK family, JAK1, JAK2, and tyrosine kinase2 
(TYK2) are widely expressed, while JAK3 is found only in cells of the hematopoietic immune 
systems.  The OB-R does not have an intrinsic tyrosine kinase domain, and therefore binds 
cytoplasmic kinases, mainly JAK2.  Box1 and Box2 motifs are known to recruit and bind JAK.  
However, for leptin signaling, it was reported that only Box1 and the immediate surrounding 
amino acids are essential for JAK activation.  The intracellular domain of all OB-R isoforms 
contains the Box1 JAK-binding domain, whereas OB-Rb also includes the Box2 motif and 
specific binding sites (Frühbeck, 2006).  Tyrosine phosphorylation sites provide binding motifs 
for src homology 2 (SH2)-domain containing proteins, such as STAT (Bjørbæk et al., 2001). 
Once bound to the leptin receptor, JAK become catalytically activated.  At the same time, 
tyrosine residues in the cytoplasmic domain of the leptin receptor become phosphorylated at 
amino acid residues Tyr985 and Tyr1138 (Banks et al., 2000).  This phosphorylation leads to the 
recruitment of STAT proteins via recognition of the receptor phosphotyrosines by the STAT 
SH2 domains.  The function of SH2 domains specifically recognizes the phosphorylated state of 
tyrosine residues.  STAT3 proteins bind to phosphorylated TYR1138, become tyrosine-
phosphorylated by JAK2 (Bjørbæk et al., 2000), then dissociate and form dimers in the 
cytoplasm.  Finally, the cytoplasmic dimers translocate to the nucleus to regulate gene 
transcription (Hegyi et al., 2004; Frühbeck, 2006).   
The JAK/STAT signaling pathway can be inhibited by a suppressor of cytokine 
signaling-3 (SOCS-3) molecule, which was the first identified negative regulator of leptin 
signaling.  This molecule is a member of the SH2 domain-containing protein family, which 
operates by binding to the phosphorylated tyrosine residues of signaling molecules and thus 
mediates either degradation or inhibition.  Bjørbæk et al. (2000) suggested that SOCS-3, via its 
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SH-2 domain, binds to Tyr985 of OB-Rb and this residue is required for maximal inhibition of 
signaling.  There is also evidence that SOCS-3 acts via a direct binding to JAK2.   Bjørbæk et al. 
(2000) further suggested that the Tyr985/SOCS-3 interaction mediates leptin-induced feedback 
inhibition of OB-Rb.  Based on the evidence, Bjørbæk et al. (2000) hypothesized that over-
reactivity of the SOCS pathway may be a potential, causal mechanism for leptin-resistant 
obesity. 
 Mitogen Activated Protein Kinase (MAPK).  Signal transduction by members of the class 
I cytokine receptor superfamily is not limited to the JAK/STAT pathway.  Some receptors are 
linked to the MAPK pathway, which is downstream from JAK (Houseknecht et al., 1998). 
 The MAPK are serine/threonine-specific protein kinases that regulate gene expression.  
Although the distal portion of OB-R is not essential for MAPK signaling, the intact, intracellular 
portion of the long receptor is needed to achieve maximal activation.  The MAPK pathway can 
be stimulated by either OB-Rb or OB-Ra, but to a lesser extent by the latter (Banks et al., 2000).   
Ligand binding to OB-Rb leads to activation of the MAPK cascade via two pathways: 1) binding 
of SHP-2 to Tyr985, followed by tyrosine phosphorylation of SHP-2; or 2) independently of 
tyrosine phosphorylation of OB-Rb, which requires the phosphatase activity of SHP-2.  Both 
pathways require an intact catalytic domain of SHP-2 (Bjørbæk et al., 2001; Hegyi et al., 2004).   
Phosphoinositol-3 Kinase (PI3-K). Leptin can also act through some of the components 
of the insulin-signaling cascade, although there are conflicting reports concerning its importance 
in modifying insulin-induced gene expression (Hegyi et al., 2004).  Many researchers support the 
idea that leptin and insulin pathways may be connected (Frühbeck, 2006; Hegyi et al., 2004), 
although the exact mechanisms by which OB-Rb activates PI3-K and the cAMP pathway are 
unknown (Bjørbæk and Kahn, 2004). 
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5’-AMP-Activated Protein Kinase (AMPK). Recent research indicated that the AMP 
kinase pathway is involved in leptin’s effect on food intake (Bjørbæk and Kahn, 2004).  This 
enzyme is a heterotrimer that functions to monitor cellular energy status; it regulates food intake 
by responding to hormonal and nutrient signals in the hypothalamus.  Activation of AMPK 
represents a signal to shut down anabolic pathways and to promote catabolic processes in 
response to a decrease in the ATP/AMP ratio by phosphorylation of key enzymes of 
intermediary metabolism.  It is not yet clear how leptin increases AMP levels and activates 
AMPK (Hegyi et al., 2004; Frühbeck, 2006). 
Diurnal Profile 
Leptin concentrations in the peripheral circulation exhibit a 24-h rhythm in both children 
and adults, with peak levels in the early morning hours and a nadir in the late morning or early 
afternoon (Licinio et al., 1998).  Other studies in humans (Licinio et al., 1998), rodents (Saladin 
et al., 1995), and horses (Piccione et al., 2004) demonstrated a significant overnight increase in 
plasma leptin concentrations.  This circadian pattern has been found in lean and obese subjects, 
with the only exception being pulse amplitude, which is higher is obese subjects.   
The circadian rhythm of leptin is similar to that of prolactin (Matkovic et al., 1997), but 
inversely related to that of ACTH and cortisol (Licinio et al., 1997).  Thyrotropin (TSH) rhythms 
have been observed to be similar to that of leptin (Mantzoros et al., 2001).  Leptin pulsatility is 
synchronous to the pulsatility of serum luteinizing hormone (LH) and estradiol levels in normal 
women, especially during the night when leptin levels are relatively high (Licinio et al., 1998). 
Several studies have shown that increases in plasma leptin can be attributed to feeding in 
humans (Schoeller et al., 1997), sheep (Marie et al., 2001), and horses (Cartmill et al., 2003).  
Cartmill et al. (2003) showed that increases in plasma leptin concentration occur 8 h after 
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increases in insulin, after a single morning meal in horses.  Additional observations from the 
same laboratory indicated that serum leptin concentrations increase postprandially in the equine 
(Cartmill et al., 2005; Crowley et al., 2005; Storer et al., 2005), perhaps stimulated by a rise in 
serum insulin concentration.  Similarly, Gordon and McKeever (2005) showed that plasma leptin 
concentration increased approximately 7 h after an observed increase in plasma insulin 
concentration.  Cartmill et al. (2005) further showed that shifting the time at which stallions 
receive the concentrate portion of their diet 12 h will also shift the peak in concentrations of 
leptin approximately 12 h and is most likely a direct result of increasing insulin concentrations 
following the meal. Similarly, it has been reported by Gentry et al. (2002) that mares in low body 
condition allowed to graze only 2 h each morning have a similar fluctuation in plasma leptin, 
further indicating that meal feeding may result in a diurnal leptin secretory pattern.  Increased 
plasma leptin concentration noted in the afternoon could be attributed to the morning feeding, 
with its subsequent insulin response (Gordon and McKeever, 2005). 
Piccione et al. (2004) reported a daily rhythm of leptin in both athletic and sedentary 
horses, with a daytime trough and a dark-phase peak.  Food deprivation did not abolish the daily 
rhythm of serum leptin, but daily mean leptin levels in fasted horses were significantly lower 
than in regularly fed horses (Piccione et al., 2004).  In other research, high-body-condition mares 
and geldings (Gentry et al., 2002; Cartmill et al., 2003), free to graze throughout the day, did not 
exhibit diurnal changes in plasma leptin.  Sheep that grazed and ruminated continuously were 
found to have no nocturnal increases in plasma leptin concentration (Marie et al., 2001).  
Although the horse is not a ruminant, the role of grazing and hindgut fermentation supports 
speculation that a more stable, continuous uptake of energy rather than fluctuations associated  
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with bolus feeding could be responsible for the relatively constant nature of plasma leptin 
concentrations (Gordon and McKeever, 2005). 
Leptin and Nutrition 
In many species, including the horse, leptin circulates in the blood at concentrations 
paralleling the amount of adiposity.  Circulating concentrations of leptin are directly correlated to 
body mass index and percentage of body fat in humans (Prolo et al., 1998; Mantzoros et al., 
2000; Agarwal et al., 1999) and in ruminants (Chillard et al., 2000; Delavaud et al., 2000).  
Studies with horses (Kearns et al., 2005; Buff et al., 2002; Ferreira-Dias et al., 2005) and sows 
(Estienne et al., 2000) also reveal that peripheral concentrations of leptin are proportional to 
adiposity.   
Inadequate nutrition and/or reduced body fat are associated with impaired reproductive 
efficiency in beef cattle (Selk et al., 1988; Schillo et al., 1992) and sheep (Schillo, 1992).  A 
similar relationship has been noted for horses (Henneke et al., 1983; Gentry et al., 2002).  Mares 
entering the breeding season or foaling in a nutritionally deprived state had prolonged 
postpartum intervals and reduced conception rates, and required more cycles per conception than 
mares entering the breeding season in fatter condition (Henneke, 1983).  Research by Gentry et 
al. (2002) concluded that nutrient restriction resulting in low BCS in mares resulted in a 
profound seasonal anovulatory period that was accompanied by lower leptin levels.   
Body weight influences fertility in mice; studies have indicated that leptin is one of the 
mediators of this effect (Greisen et al., 2000).  In mares in good body condition, leptin secretion 
increases from the anovulatory period to the first follicular and luteal phases of the breeding 
season (Ferreira-Dias et al., 2005).  These observations are consistent with previous findings by 
Gentry et al. (2002), who concluded that in mares with low body condition had low leptin levels, 
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and both were accompanied by a deep seasonal anovulatory period.  In the Lusitano mare, a 
transition from ovarian activity to a seasonal anovulatory state is preceded by a decrease in 
plasma leptin concentrations.  Resumption of ovarian activity seems to require that leptin rises 
again to a threshold level (Ferreira-Dias et al., 2005). 
In contrast to low leptin concentrations, chronically persistent hyperleptinemia, as seen in 
obesity, can interfere with gonadotropin stimulation of peripheral targets.  In obesity, leptin 
central receptors, which are sensitive to extremely low ligand concentrations, are protected from 
hyperleptinemia by the saturable transport system of the blood-brain barrier, whereas peripheral 
leptin receptors are directly exposed to high ligand concentrations, with possible negative effects 
on gonadal steroidogenesis (Caprio et al., 2001).  Spicer (2001) suggested that, in a high leptin 
environment, as observed with obesity, the ovary is kept from over-producing estradiol by 
leptin’s inhibition of insulin-induced steroidogenesis.  Leptin has been shown to inhibit insulin-
induced androstenedione production by bovine thecal cells in vitro (Spicer, 2001). 
The Hypothalamic-Pituitary-Gonadal Axis 
 The Estrous Cycle.  The estrous cycle of the mare is divided into the follicular phase and 
the luteal phase (McKinnon and Voss, 1993).  Estrus is the period of sexual receptivity 
(Higgings and Snyder, 2006).  The average length of the estrous cycle in the mare population 
during the physiologic breeding season is 21 d, with estrus comprising 5 to 7 of these days 
(McKinnon and Voss, 1993).   
 The Follicular Phase.  The follicular phase is characterized by follicular growth with 
estrogen production.  The dominant follicle develops and secretes estradiol-17β, which induces 
sexual receptivity.  Estradiol reaches peak concentrations of greater than 30 to 40 pg/mL 2 to 3 d 
before ovulation (Sharp and Porter, 2004) and is thought to contribute to the final maturation of 
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the pre-ovulatory follicle by stimulating further LH release.  A preovulatory LH surge develops 
progressively over approximately a week, beginning near deviation and extends for an average of 
1 d after ovulation; the LH surge then gradually recedes over several days (Ginther et al., 2005).  
Ovulation, the release of the oocyte, occurs approximately 24 to 28 h before the end of sexual 
receptivity (McKinnon and Voss, 1993).   
The Luteal Phase.  The luteal phase is initiated at ovulation by the formation of a 
progesterone-secreting corpus luteum (CL).  Elevated concentrations of plasma progesterone are 
detected within 24 h and estrus behavior ceases (Higgins and Snyder, 2006).  Maximum 
circulating progesterone concentrations are reached by 6 d postovulation and then plateau.  
Hypothalamic GnRH is suppressed by the negative feedback action of progesterone.  The life 
span of the CL depends on the endogenous release of prostaglandin-F2α (PGF2α), released in 
bursts from the endometrium between d 13 and 16 postovulation.  The PGF2α is absorbed into 
the uterine venous drainage, enters the circulation, and reaches the ovaries by a systemic route.  
Rapid luteolysis of the CL is caused by PGF2α, resulting in a decline in circulating progesterone 
concentration.  This decrease in circulating progesterone removes negative feedback on the 
pituitary and hypothalamus; consequently, plasma concentrations of GnRH increase and the 
mare returns to estrus (Higgins and Snyder, 2006). 
Gonadotropin Releasing Hormone.  In the horse, GnRH is relatively evenly distributed 
throughout the hypothalamus.  The release of GnRH into the hypothalamic-hypophyseal portal 
system stimulates the synthesis and release of LH and follicle-stimulating hormone (FSH) from 
the adenohypophysis.  Although the major function of GnRH is to stimulate gonadotropin 
secretion, it also stimulates production of its own receptor.  Inhibitory influences on GnRH 
secretion include corticotropin-releasing factor and progesterone (McKinnon and Voss, 1993).   
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Follicle Stimulating Hormone and Luteinizing Hormone.  The two gonadotropins, LH 
and FSH, enter the systemic circulation and travel to the ovary, where FSH is responsible for 
follicular recruitment, while LH is responsible for follicular maturation and production of 
estrogen, ovulation, and luteinization of the CL.  Receptors for FSH are found mainly on the 
granulosa cells in ovarian follicles.  Receptors for LH are confined to the thecal cells and other 
types of ovarian interstitial cell.  However, after antrum formation, LH receptors also appear on 
granulosa cells.  Both antrum formation and the induction of LH receptors on granulosa cells 
require the presence of FSH and estradiol.  As the follicle matures, theca and granulosa cells 
cooperatively secrete estradiol (McKinnon and Voss, 1993).   
In the mare, LH concentrations are low during the mid-luteal phase, but rise in a 
prolonged ovulatory surge, beginning a few days before the onset of estrus, peaking on the day 
after ovulation, and returning gradually over several days to mid-luteal phase values.  Unlike LH, 
FSH shows a biphasic profile during the cycle, with surges at 10 to 12 d intervals.  One surge 
occurs at or just after ovulation, and the second surge occurs during mid- to late-luteal phase, 
approximately 10 d before the next ovulation.  In early estrus, FSH concentrations reach their 
lowest value in the cycle (McKinnon and Voss, 1993).   
Inhibin.  Inhibin is a glycoprotein hormone, produced predominantly by granulosa cells 
of the ovary.  The major physiologic role of inhibin is the specific suppression of FSH secretion 
from the adenohypophysis (Roser et al., 1994; Ginther et al., 2005).  The production of inhibin is 
stimulated by FSH, thereby forming a negative feedback circuit.  In the mare, inhibin may not be 
the sole inhibitor of FSH, but likely acts synergistically with estradiol (McKinnon and Voss).   
Progesterone.  Progesterone is secreted by the CL, and can act at either the hypothalamus 
or pituitary to influence gonadotropin secretion.  Progesterone inhibits GnRH release.  
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Concentrations of progesterone rise after ovulation and maintain high levels until approximately 
3 d before estrus, when the CL is lysed (McKinnon and Voss).   
 Estradiol.  Estradiol can act at either the hypothalamus or pituitary to influence gonado-
tropin secretion.  Estrogen activates GnRH release.  When estradiol reaches a certain threshold 
level, large quantities of GnRH cause the release of large quantities of LH that stimulate 
ovulation (Senger, 2003).  Estradiol is produced by the maturing ovarian follicle.  Estradiol 
begins to increase 6 to 8 d before ovulation, rising progressively to peak about 2 d before 
ovulation.  High estradiol concentrations initially inhibit LH, but then trigger an ovulatory LH 
surge.  Most research suggests that the inhibitory effect of estradiol is exerted directly on the 
gonadotropes (McKinnon and Voss, 1993).   
Insulin-like Growth Factor-I.  In mares, plasma insulin-like growth factor I (IGF-I) 
increased continuously during late gestation, peaked 2 d after parturition, and then gradually 
declined until weaning.  Circulating IGF-I in mares was maintained at high concentration during 
early lactation, before decreasing (Hess-Dudan et al., 1994).  Research by Heidler et al. (2003) 
revealed that the highest IGF-I levels were found in lactating mares in the week of foaling, 
followed by a continuous decrease in IGF-I concentrations.  Heidler et al. (2003) suggested that 
increased IGF-I concentrations during early postpartum might contribute to ovarian stimulation.  
This may explain why most mares ovulate reliably in foal heat. 
 Leptin.   Leptin has emerged as a potential regulator of reproduction (Spicer, 2001).  
Leptin can affect the hypothalamic-pituitary-gonadal axis by direct actions in the hypothalamus, 
the pituitary gland, and the gonads (Mantzoros et al., 2000; Spicer, 2001).  In the hypothalamus, 
leptin stimulates the release of GnRH; in the pituitary, leptin stimulates LH and FSH release; and 
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in the ovary, leptin impairs the IGF-I mediated augmentation of estradiol-17β synthesis by 
granulosa cells (Licinio et al., 1998). 
The effect of leptin on the reproductive system is primarily mediated by its hypothalamic 
receptor, eliciting the release of GnRH, which subsequently induces the synthesis and release of 
pituitary FSH and LH.  Recent research demonstrated that leptin induces the release of GnRH 
through inhibition of hypothalamic neuropeptide Y (NP-Y) production.  Research in healthy 
women also indicates that serum leptin rises during the follicular phase, and then reaches a peak 
at the luteal phase of the reproductive cycle - a finding that strongly links leptin with ovulation 
(Barkan et al., 2004; Spicer, 2001).   
During pregnancy, especially in the second and third trimesters, serum leptin levels rose 
in both animal models and humans, and dropped sharply after parturition (Caprio et al., 2001).  
Placental production of leptin may be a major contributor to the increase in maternal leptin; 
leptin receptors exist in placental tissues and may regulate metabolism of the fetal-placental unit 
(Spicer, 2001).   
Research with dairy cows showed that the plasma concentration of leptin decreased by 
approximately 50% after parturition and remained depressed during lactation, despite a gradual 
improvement in energy balance.  The reduction could benefit early lactating dairy cows by 
promoting a faster increase in feed intake and by diverting energy from non-vital functions such 
as reproduction (Block et al., 2001).  In mares, plasma leptin concentrations decreased after 
foaling, and for 4 wk were lower in lactating than in non-lactating mares.  Reduced leptin 
concentrations may promote feed intake and allow lactating mares to avoid an energy deficit 
(Heidler et al., 2003).  In contrast to cattle, most lactating mares resume follicular growth and 
ovulation in early postpartum (Ginther, 1993), and ovulation is not impeded by suckling or the 
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presence of a foal. The majority of foaling mares show estrous behavior and ovulate within 15 
days after foaling (Neuschaefer et al., 1990), therefore lactational anestrous does not exist as a 
principal physiological condition in the horse (Heidler et al., 2004).  Lactation, on average, is not 
associated with weight loss in mares, as the mare seems able to compensate energy losses mainly 
by increasing feed intake, rather than by mobilization of body reserves.  Recent research by 
Heidler et al. (2004) suggested that a negative energy balance during lactation in most horse 
breeds may be prevented by adequate feeding.  The reduced leptin concentrations in postpartum 
mares may therefore encourage feed intake, which would allow the lactating mare to avoid an 
energy deficit.   
Leptin seems to have both a central stimulatory and a peripheral inhibitory effect on 
ovarian function.  Much of the available data indicates that leptin acts centrally to stimulate 
pituitary gonadotropin secretion (Greisen et al., 2000).  In contrast, peripheral leptin receptors, 
directly exposed to high ligand concentrations, can have negative effects on gonadal 
steroidogenesis (Spicer, 2001).  Caprio et al. (2001) hypothesized that a specific and narrow 
range of leptin concentrations is necessary to maintain a normal, reproductive function in both 
sexes, and that concentrations below or above these thresholds might interfere in opposing ways 
with the function of the hypothalamic-pituitary-gonadal axis. 
Leptin is present in follicular fluid, and the receptor is expressed in the ovaries of the 
human (Greisen et al., 2000; Mantzoros et al., 2000) and the cow (Spicer and Francisco, 1998).  
The identification of OB-R expression in the ovary indicates that leptin might have a direct effect 
on downstream endocrine targets of the reproductive axis.  Both ovarian granulosa and theca 
cells have high affinity receptors for leptin (Spicer, 2001).  There seems to be no physiologically 
important difference between circulating leptin levels and follicular fluid leptin concentrations 
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(Agarwal et al., 1999; Bützow et al., 1999).  However, research by Mantzoros et al. (2000) found 
that lower follicular fluid leptin concentrations were a marker of assisted reproduction treatment 
success in normal women, indicating that high leptin concentrations in the ovary may suppress 
estradiol production and interfere with the development of dominant follicles and oocyte 
maturation.   
Spicer and Francisco (1998) found that insulin and IGF-I represent potent stimulators of 
theca cell proliferation and steroidogenesis.  Research with rats (Hernandez et al., 1988), pigs 
(Caubo et al., 1989), and humans (Bergh et al., 1993) confirmed a role for IGF-I and insulin as 
regulators of steroidogenesis by theca cells.   Insulin and IGF-I enhanced FSH-induced 
aromatase activity in cultured bovine and rat granulosa cells, in part, by increasing numbers of 
FSH receptors and mRNA for the FSH receptor.  Similarly, insulin and IGF-I also enhance LH-
induced androstenedione production by bovine thecal cells by increasing the number of LH 
receptors (Stewart et al., 1995; Spicer et al., 2002).   
Further studies by Spicer and Francisco (1998) indicated that leptin inhibits insulin-
induced progesterone and androstenedione production by theca cells.  In vitro studies, conducted 
on theca and granulosa cells, showed that leptin has a negative effect on ovarian steroid output.  
Human research by Agarwal et al. (1999) indicated that in cultured granulosa cells, leptin had no 
effect on estradiol production, alone or in the presence of FSH, but caused a concentration-
related inhibition of insulin-like growth factor I (IGF-I) augmentation of FSH-stimulated 
estradiol production.  Consistent with these findings, it has been shown that the incubation of 
granulosa cells from fertile women with leptin, at concentrations between 10 and 100 ng/mL, 
inhibits FSH- and IGF-1-stimulated estradiol production.  Greisen et al. (2000) suggested that 
leptin acts directly to inhibit basal and FSH-stimulated estradiol and progesterone production in 
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cultured human granulosa cells.  These observations indicate that leptin, at concentrations 
commonly found in obese women, has the potential to interfere with estradiol production by the 
dominant follicle in vivo, either directly or through a reduction of the androgenic substrate 
derived by theca cells.  If elevated leptin levels interfere with the development of the dominant 
follicle and reduce estradiol production, there would be no adequate stimulus for LH secretion, 
which would result in no ovulation (Caprio et al., 2001; Greisen et al., 2000). 
The aforementioned research indicates that high physiological concentrations of leptin 
could significantly interfere with the ability of the dominant follicle to produce estradiol, both by 
inhibiting the production of androgen substrate and by decreasing the aromatizing capacity of 
granulosa cells.  Such an effect could result in an inadequate stimulus for the LH surge and may 
also lead to an immature preovulatory follicle, or in extreme cases,  no preovulatory follicle at 
all.  This type of mechanism is consistent with clinical observations that obese women have a 
higher incidence of infertility, and that weight loss often causes significant clinical improvement 
(Agarwal et al., 1999). 
Kitawaki et al. (1999) reported that a leptin concentration of 1 ng/mL augments basal, 
FSH and FSH- and IGF-I-stimulated aromatase activity, and estrogen production in human 
granulosa luteal cells.  Greisen et al. (2000) reported an inhibitory effect of leptin on basal and 
FSH-stimulated progesterone production at 20 ng/mL, whereas 100 ng/mL had no significant 
effect.  Leptin, in a concentration of 30 ng/mL, may impair basal, but not FSH-stimulated, 
progesterone production in bovine granulosa cells in vitro (Spicer and Francisco, 1997).   
Most immunologic, hormone, and cytokine receptors respond to stimulation with a bell-
shaped dose-response curve, and this may well be the case for the inhibitory actions of leptin.  In 
a study by Zarkesh-Esfahani et al. (2000) on the effects of a high dose of growth hormone, it was 
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shown that high concentrations of growth hormone actually prevented dimerization of the 
receptors, as well as signaling (Waters et al., 2006).  Both OB-R and the growth hormone 
receptor (GHR) belong to the cytokine receptor superfamily and are mediated by JAK2 upon 
ligand-receptor interaction.  In responsive cells, receptor dimerization is the rate-limiting step in 
GH signaling.  Yet a lesser number of available JAK2 molecules may also make activation of 
JAK2 into a rate-limiting step.  In cells where the availability of the effector kinase (JAK2) is 
high, the effect will become a bell-shaped, dose-response curve, due to complete dependency 
upon receptor dimerization (Ridderstråle, 2005).  It is possible that the overall effect of leptin 
may depend on the concentration in the circulation.  The central stimulatory role of leptin seems 
to be predominant in non-obese states, where leptin may play a permissive role for both sexual 
maturation and reproductive function.  The direct negative peripheral action of leptin on the 
ovary may be expressed during conditions of elevated circulating levels, such as in obesity 
(Greisen et al., 2000).   
The Hypothalamic-Pituitary-Adrenal Axis 
 The end result of the hypothalamic-pituitary-adrenal (HPA) axis activation is a rise in 
plasma corticosteroid concentrations (Alexander and Irvine, 1998).  The HPA axis is a key 
component of the host response to sepsis.  During an acute illness, such as sepsis, circulating 
pro-inflammatory cytokines, including IL-6 and TNF-α, stimulate the production of 
corticotrophin-releasing hormone (CRH) and subsequently adrenocorticotrophic hormone 
(ACTH).   
 Upon ACTH stimulation, glucocorticoids are synthesized by the adrenal cortex from 
cholesterol.  A small amount of corticosterone is stored as a sulphate conjugate in the adrenal 
cortex.  However, the amount of glucocorticoid found in adrenal tissue is not sufficient to 
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account for the initial rise in cortisol that occurs following stress, and it is not sufficient to 
maintain normal rates of secretion for more than a few minutes in the absence of continuing 
biosynthesis.  In other words, any disruption in glucocorticoid synthesis will immediately result 
in glucocorticoid insufficiency (Prigent et al., 2004). 
Adrenocorticotrophic hormone increases cortisol release from the adrenal glands, which 
then binds to a specific carrier, cortisol-binding globulin (CBG), which is synthesized by the 
liver.  The percentage of CBG-bound corticosteroid ranges between 67 and 87% in several 
domestic species, including the horse (Gayrard et al., 1996).  Elastase, produced by neutrophils, 
liberates cortisol from CBG, allowing localized delivery of cortisol.  Then, cortisol can freely 
cross the cell’s membrane, or it may interact with specific membrane binding sites (Prigent et al., 
2004). 
Tissue levels of cortisol are also regulated by enzymatic conversion of cortisol to its 
inactive form, cortisone, by 11β-hydroxysteroid dehydrogenase (11 β-HSD) type 2.  Conversely, 
the conversion from inactive cortisone to the active cortisol is by 11β-HSD type 1.   Research has 
shown that TNF-α up-regulates 11β-HSD-1 and decreases 11β-HSD-2 activity (Prigent et al., 
2004). 
 Cortisol is the physiological glucocorticoid in horses.  Production of cortisol is increased 
with stress and represents an essential, physiological adaptation that promotes survival. Stress-
induced cortisol secretion ensures that adequate nutrients are supplied to the brain and other 
areas of the body that might be compromised by the stressful event.  Cortisol secretion releases 
amino acids from the muscle, glucose from the liver, and fatty acids from adipose tissue into the 
blood stream for use as energy.  Cortisol also reverses and suppresses the inflammatory 
responses which accompany stress (Johnson, 2002). 
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 Glucocorticoids specifically inhibit the production of pro-inflammatory cytokines, 
whereas anti-inflammatory cytokines remain unaffected or are even stimulated.  By these effects, 
the HPA axis acts as a regulatory feedback loop that shuts off inflammatory responses to 
invading antigens after the initial stress response (Rohleder et al., 2001). 
 Normal cortisol secretion undergoes a diurnal rhythm, with the highest levels typically 
observed in the early morning and the lowest levels in the early hours (about midnight to 2 am).   
According to Irvine (1994), a circadian rhythm in plasma cortisol concentrations occurred in 
some, but not all, horse studies.  When a rhythm occurred, horses were accustomed to a 
management routine, which may entrain a circadian pattern.  Irvine concluded that a circadian 
cortisol rhythm exists in horses in the absence of any known cues imposed by humans.  
However, this rhythm can be obliterated by the minor perturbation of removing the horse from 
its accustomed environment. 
 In animal studies, the female sex steroids, especially estrogens, stimulated glucocorticoid 
secretion, whereas the male sex steroid, testosterone, had an inhibitory impact (Rohleder et al., 
2001).  Animal studies showed that ovariectomy leads to attenuated HPA responses, where 
estradiol substitution induces HPA stimulation.  In rodents, basal ACTH and corticosterone 
levels, as well as response to various stimuli, are uniformly greater in females (Kirschbaum et 
al., 1999).   
Leptin and the Immune System 
 To further understand the cause behind the increase in equine obesity, understanding the 
underlying relationship between adiposity and chronic inflammation becomes essential. 
Cytokines, including IL-6, TNF-α, and leptin, play important roles in the inflammatory 
processes.  During infection, pro-inflammatory cytokines are released that induce regulated 
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changes in the host’s internal environment, which in turn creates a hostile environment to the 
invading pathogen.  However, recent evidence indicates that certain cytokines are produced at a 
low, constant rate in a non-pathological, obese state (Cannon, 2000).  In obesity, the normal 
balance of certain adipose cytokines is perturbed (Rajala and Scherer, 2006).  According to 
Rudin and Barzilai (2005), low-grade inflammation is a predominant feature of obesity and may 
be linked to chronic activation and secretion of cytokines IL-6, TNF-α, and leptin.  Additionally, 
adipose tissue is infiltrated by macrophages, which may also be a major source of locally-
produced pro-inflammatory cytokines. 
Tumor Necrosis Factor-α.  While predominantly synthesized and secreted by phagocytic 
cells of the immune system, TNF-α has also been shown to be synthesized and secreted by the 
adipocytes (Qi and Pekala, 2000).  The expression and circulating levels of TNF-α are elevated 
in obese subjects.  In the basal state, TNF-α is directly proportional to fat mass and has been 
shown to be involved in the development of insulin resistance (Badman and Flier, 2007). 
 Tumor necrosis factor-α is believed to be involved in the wasting that occurs during 
acute and chronic illness and malignancy of human patients.  Levels of TNF-α are elevated with 
various cancers, AIDS, and sepsis, all of which cause a reduction in skeletal muscle protein 
synthesis and a loss of muscle mass (Williamson et al., 2005).  While insulin stimulates protein 
synthesis in skeletal muscle, elevated concentrations of TNF-α in blood have been shown to 
inhibit insulin-stimulated pathways (Williamson et al., 2005).  In-vitro studies have demonstrated 
that TNF-α decreases the insulin receptor tyrosine phosphorylation by down-regulating several 
steps in the insulin signaling pathway.  Neutralizing agents for TNF-α, however, improve insulin 
resistance (Rudin and Barzilai, 2005).   
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In studies of experimentally induced endotoxemia in horses, serum concentrations of 
TNF-α activity increased to peak values within the first 2 h after the onset of endotoxemia, and 
then returned to baseline values by 6 h (Morris et al., 1990; MacKay et al., 1991).  The early 
increase in serum TNF-α activity was directly associated with the onset of signs of abdominal 
pain or depression, fever, and leucopenia (Morris et al., 1990). 
During systemic bacterial infection, animals achieve an internal homeostasis by 
balancing the activities of pro-inflammatory and anti-inflammatory pathways.  The toxicity and 
lethality induced by TNF-α is largely dependent on the presence and absence of endogenous 
sensitizing or protective factors (Takahashi et al., 1999).  One of the cytokines that is induced by 
TNF-α is leptin (Sarraf, et al., 1997; Grunfeld, et al., 1996).  Leptin production in rodents is 
increased after administration of TNF-α (Grunfeld, et al., 1996).  Leptin has protective properties 
against the toxicity exerted by TNF-α, thus leptin might be an anti-stress cytokine (Takahashi et 
al., 1999). 
 Interleukin-6.  Interleukin-6 is another cytokine derived from adipose tissue.  Its 
expression and circulating levels correlate directly with obesity; weight loss will lower 
circulating levels.  Indeed, adipose tissue has been estimated to yield approximately a third of 
circulating IL-6, with visceral fat contributing more than subcutaneous adipose tissue (Badman 
and Flier, 2007).  Elevation of circulating IL-6 is a predictor of the development of 
cardiovascular disease and diabetes (Rudin and Barzilai, 2005). 
Leptin.  Leptin is a member of the cytokine family.  Although a cytokine itself, leptin 
synthesis is stimulated by cytokines.  The leptin receptor is highly expressed in the 
hypothalamus, but is also present in peripheral tissues, including those of the immune system 
such as spleen, thymus, lung and leukocytes (Faggioni et al., 2001).  Leptin levels increase 
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acutely during infection and inflammation, and may serve a protective role against damage by 
pro-inflammatory cytokines such as TNF-α (Henson and Castracane, 2003).  Leptin deficiency is 
known to increase susceptibility to lipopolysaccharide (LPS) and TNF-α induced lethality; ob/ob 
mice have a greater number of monocytes and dysfunctional macrophages, together with higher 
levels of pro-inflammatory cytokines and lower concentrations of anti-inflammatory cytokines 
(Takahashi et al., 1999).     
Studies in ob/ob and db/db mice (Loffreda et al., 1998) have demonstrated that the 
absence of leptin, or of a functional leptin receptor, leads to impaired macrophage phagocytosis 
and abnormal cytokine gene expression, rendering these animals more susceptible to infection by 
various pathogens.  Using the acute starvation model, Lord et al. (1998) reported that leptin 
administration to leptin-deficient mice reversed the immunosuppressive effects of acute nutrient 
deprivation.  Together, these findings suggest a novel role for leptin in relating nutritional status 
to the regulation of cellular immune function (Henson and Castracane, 2003). 
In contrast to leptin deficiency, an excess of leptin, correlating with overweight in obese 
subjects, may play a role in pathological conditions mediated by an excess of immune response.  
Elevated leptin levels, along with proinflammatory cytokines, have been associated with an 
increased risk for coronary heart disease (Yudkin et al., 1999) and type II diabetes (Matarese et 
al., 2002).  Leptin, along with other cytokines, such as TNF-α and IL-6, may contribute to the 
biochemical and clinical features of the metabolic syndrome X, including accelerated 
atherosclerosis associated with insulin resistance, glucose intolerance, and central obesity 
(Pickup et al., 1997). 
Endotoxemia.  Endotoxemia remains the leading cause of death in horses, being directly 
involved in the pathogenesis of gastrointestinal disorders that cause colic and neonatal foal 
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septicemia (Morris, 1991; Ouellette et al., 2004; Sykes and Furr, 2005).  Compared to other 
animal species, horses display extreme sensitivity to endotoxin-induced, cardio-pulmonary 
shock; however, the mechanisms behind increased sensitivity of the horse to endotoxins remain 
largely unknown (Morris, 1991; Parbhakar et al., 2005).  During experimental studies, both 
horses and humans have shown to be more sensitive to the effects of endotoxin than rodents 
(Van Miert, 2002).  Previous experiments with the horse have even shown large inter-individual 
variations in the response to endotoxins (Werners et al., 2005). 
 Endotoxin, or LPS, is a glycolipid that constitutes the major portion of the outermost 
membrane of gram-negative bacteria.  Endotoxemia occurs when gram-negative bacteria, during 
rapid growth or death, release their endotoxins, which subsequently gain access to the systemic 
circulation (Fenton and Golenbock, 1998).   Endotoxemia is characterized by global activation of 
inflammatory cells, secretion of pro-inflammatory mediators, and possible development of shock 
and multiple organ failure (Parbhakar et al., 2005). 
 Lipopolysaccharide is composed of three parts, each of which has important biologic 
characteristics.  The innermost portion is termed the lipid A, unique because it is well-conserved 
among different species of gram negative bacteria, and because lipid A imparts toxic qualities to 
the endotoxin molecule.  The middle region of endotoxin is the core oligosaccharide, which links 
the lipid A with the outer polysaccharide portion.  The core region is well conserved in gram-
negative bacteria.  The outermost portion is comprised of repeating polysaccharides.  The 
composition of this portion is especially diverse and accounts for the serologic differentiation 
among bacterial species.  The interaction of the lipid A moiety of LPS with macrophages appears 
to be especially important, because subsequent cellular activation results in the release of 
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systemically active pro-inflammatory molecules, which in turn mediate systemic toxicity (Hardie 
and Kruse-Elliot, 1990; Fenton and Golenbock, 1998).   
 Bacteria do not actively secrete endotoxin.  Rather, when gram negative bacteria undergo 
periods of rapid proliferation or lyse upon bacterial cell death, endotoxin is released from the 
outer cell membrane (Morris, 1991; Moore and Barton 1999).  The lumen of the equine 
gastrointestinal tract harbors large quantities of gram-negative bacteria and free endotoxin.  In 
fact, it has been estimated that at least 2.25 g of free endotoxin exists in the cecum and ventral 
colons of healthy mature horses (Moore and Barton, 1998).   
  Once in the systemic circulation, LPS associates with high-density lipoproteins (HDL) or 
lipopolysaccharide-binding protein (LBP), which has a strong affinity for the lipid A region of 
endotoxin (Fenton and Golenbock, 1998; Peppelenbosch et al., 1999).  Lipopolysaccharide-
binding protein serves as a transporter, shuttling molecules of endotoxin to various locations.  
Lipopolysaccharide-binding protein is an acute-phase reactant, predominantly derived from the 
liver, and plasma levels rise dramatically after inflammatory challenge, including bacterial 
sepsis.  It can also be synthesized in the lung; local production of LBP might account for many 
of its biological effects.  Through its interaction with lipid A, LBP effectively imprisons 
endotoxin, with its potential for toxicity determined by the complex’s final destination.  
Lipopolysaccharide-binding protein can rapidly deliver monomers of endotoxin to the cell 
surface of host inflammatory cells to evoke an inflammatory response.  A second accepted role 
of LBP is to shuttle LPS into HDL particles, resulting in LPS neutralization.  The plasma half-
life of LPS is generally very short; however, this varies with animal species and functional 
capacity of the mononuclear phagocyte system (Morris, 1991). 
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Macrophages.  Macrophages play a pivotal role in the pathophysiology of many diseases 
by mediating the host immune response to infections and toxins.  Werners et al. (2004) 
concluded that, in response to inflammatory stimuli, macrophages produce the pro-inflammatory 
cytokine TNF-α, which plays an important role in the network of mediators, and is released 
during or after the onset of the acute phase response.  Stimulation of an equine macrophage cell 
line, derived from equine bone marrow cells, with increasing concentrations of LPS resulted in a 
dose-dependent increase in TNF-α production (Werner et al., 2004). 
Hematologic Variables.  Red blood cell (RBC) counts, reported in units of millions/μl, 
measure the number of circulating erythrocytes in circulating blood.  Packed cell volume (PCV) 
measures that space in the blood which is taken up by RBC; PCV is reported as a percentage.  A 
high PCV (greater than 45%) generally indicates dehydration.  Stress, excitement, or pain may 
elevate red cell values, as RBC are mobilized from the spleen.  This effect may last for 
approximately 60 min, depending on the level of stress.  (Rose and Hodgson, 2000). 
 Total protein (TP) measures the total amount of protein in serum, and is unaffected by 
excitement.  An increase in TP occurs in conditions of dehydration, with values greater than 7.5 
g/dL, indicating sodium and water loss.  Greater than normal values may indicate chronic 
inflammation or infection (Rose and Hodgson, 2000).   
 White blood cell counts (WBC) measure the total number of leukocytes, and are reported 
in units of millions/μl.  A decrease in total WBC to below normal range (leukopenia) is always a 
pathologic event, and may be associated with stress or endotoxemia.  Absolute counts of the 
different leukocyte populations are more meaningful than total WBC counts (Sprayberry, 1999). 
 Neutrophils are the first line of defense against microbial infection.  Neutrophils are 
attracted to sites of infection and inflammation by soluble chemotactic factors released during a 
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pro-inflammatory reaction.  Neutrophils ingest and kill invading microorganisms at the site of 
tissue injury (Reed et al., 2004).  The mature neutrophil has a segmented nucleus, while the 
immature neutrophil has a band-shaped nucleus.  The most notable indicator of infectious, 
inflammatory disease is the presence of increased numbers of circulating immature neutrophils in 
the circulation.   A “degenerative left shift” occurs when the immature cells are more prevalent 
in the circulation, as the bone marrow cannot keep up with adequate production (Sprayberry, 
1999).  Neutropenia occurs when the demand for neutrophils exceeds bone marrow production.  
Experimentally, administration of endotoxin to horses results in neutropenia within 90 min with 
a return to baseline numbers within 6 to 18 h (Reed et al., 2004).  Endotoxemia causes increased 
expression of adherence molecules on the vascular endothelium, making them stickier so that 
neutrophil margination (flowing nearer to the endothelial lining of blood vessels) increases, thus 
decreasing neutrophil cell numbers in peripheral blood samples.  Gram-negative sepsis is one 
type of bacterial infection that can result in neutropenia, rather than neutrophilia (Sprayberry, 
1999). 
 Lymphocytes are the primary mediators of humoral and cell-mediated immune responses.  
Two major types of lymphocytes are T lymphocytes that mature in the thymus, and B 
lymphocytes that mature in the bone marrow and then migrate to lymph nodes.  Circulating 
lymphocytes are predominantly of the T-cell type; however, they represent only a small fraction 
of the total pool of lymphocytes.  Most lymphocytes reside in the spleen, lymph nodes, and other 
lymphoid tissue of the body.  The spleen plays a major role in immune defense, and contains the 
greatest number of lymphocytes in the adult horse (Reed et al., 2004).  Lymphopenia is 
frequently associated with glucocorticoid administration, severe systemic stress, and acute 
systemic infections in the horse (Rose and Hodgson, 2000). 
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 Platelets are formed in the bone marrow from megakaryocytes.  Platelets are irregularly-
shaped, circulating fragments of megakaryocytes that are essential for the formation of primary 
hemostatic plugs (Guyton and Hall, 2000).  Normal equine platelets have a life span of 4 to 5 d 
(Reed et al., 2004).  Vikenes et al (1999) reported that blood platelets are involved in the 
formation of plaque on the inner lining of arteries.  Experimental animal studies have 
demonstrated that platelets are activated and aggregate at the sites of coronary artery stenosis and 
endothelial injury.  Activated platelets release serotonin in substantial quantities, causing further 
vasoconstriction and recurrent aggregation of platelets with cyclic flow reductions (Vikenes et 
al., 1999).  The release of the vasoconstrictor substance thromboxane A2 by platelets (Guyton 
and Hall, 2000) has been shown to act synergistically with serotonin to cause vasoconstriction, 
platelet aggregation, and reduction in blood flow (Vikenes et al., 1999). 
 Nakata et al. (1999) and Konstantinides et al. (2001) reported that platelets express the 
long form of the leptin receptor (Ob-R).  Research indicates that leptin may be responsible for 
the association between obesity and blood clots, which can lead to heart attacks and strokes.  
Research has shown that at the lower leptin concentrations, as are observed in normal 
individuals, leptin had no effect on platelet aggregation.  However, when leptin concentrations 
were high, as seen in obese individuals, there was a significant increase in platelet aggregation 
(Nakata et al., 1999).  Konstantinides et al. (2001) stated that leptin potentiates the aggregation 
of platelets from ob/ob, but not db/db, mice in response to known agonists.  The authors 
suggested that there exists a receptor-dependent effect of leptin on platelet function and 
hemostasis.  These results provided evidence for a link between leptin and the risk for thrombotic 
complications in obese individuals. 
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Thrombocytosis is an increase in the number of circulating platelets.  Increased bone 
marrow production of megakaryocytes may occur as a result of acute or chronic inflammatory 
disorders (Reed et al., 2004).  Increased IL-6 production, as part of the acute-phase inflammatory 
response, may stimulate increased bone marrow platelet production.  Extremely high platelet 
counts could lead to thrombosis, possibly increasing the risk of equine laminitis or organ 
dysfunction (Brown and Bertone, 2002). 
Clinical Signs of Disease.  Moore and Barton (1998) reported that the most common 
clinical effects of endotoxemia are increased heart and respiratory rates, alterations in the color 
of the horse’s mucous membranes, prolongation of the capillary refill time, fever, and reduced 
gastrointestinal sounds.  The presence of endotoxins in the blood simultaneously initiates 
numerous processes involving the cardiovascular and the pulmonary systems.  The degree of 
dysfunction within these two systems is determined by the severity and rate of development of 
endotoxemia.   
Research with horses that were given various doses of LPS by several routes of 
administration showed that endotoxin causes early systemic vasoconstriction, tachycardia, and 
pulmonary hypertension (Morris, 1991).  Interestingly, the responses to bolus administration of 
high dosages of endotoxin and slow infusion of low doses of endotoxin differ.  It has been shown 
that bolus administration of endotoxin elicits the release of overwhelming quantities of 
mediators, resulting in severe insult.  In contrast, slow infusion is a pathophysiologically more 
relevant method of study (Clark and Moore, 1989).  Clark and Moore (1989) indicated that all 
horses in the experiment that received a slow infusion of a low dosage of endotoxin became 
depressed, displayed dark red and dry mucous membranes, and showed a significant increase in 
heart rate, respiratory rate and body temperature.  Congestion and discoloration of mucous 
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membranes, along with a prolongation of the capillary refill time, are normally found in horses 
with endotoxemia (Morris, 1991).   
At rest, the equine heart rate is usually in the range of 30 to 40 beats per minute (Rose 
and Hodgson, 2000).  The normal respiration rate for a horse is 8 to 16 respirations per minute, 
while the normal rectal temperature is 38º C for adult horses (Evans, 2001).  The mucous 
membranes of the horse are normally pale pink and should feel moist to the palpating finger.  
Capillary refill time is 1 to 2 sec (Rose and Hodgson, 2000).  Gut sounds are caused by the 
normal contracting and relaxing movements of the digestive tract during the digestion process.  
Absence of gut sounds is usually more critical than excessive sounds (Evans, 2001). 
Pro-inflammatory Cytokines.  Cytokines are not produced solely from the consequences 
of endotoxemia.  Obesity is associated with a low-grade inflammation of white adipose tissue 
resulting from chronic activation of the innate immune system.  In obesity, white adipose tissue 
is characterized by an increased production and secretion of a wide range of inflammatory 
molecules including TNF-α and IL-6, which may have local effect on white adipose tissue 
physiology, but also systemic effects on other organs.  A recent study indicated that white 
adipose tissue in obesity is infiltrated by macrophages, which may be a major source of locally-
produced pro-inflammatory cytokines (Bastard et al., 2006). 
 Prolactin.  Prolactin is a polypeptide protein hormone that is predominantly synthesized 
in and secreted from specialized cells of the anterior pituitary gland and the lactotropes (Freeman 
et al., 2000).  Recent research concluded that prolactin is a multi-functional hormone and is 
secreted not only by the anterior pituitary gland, but also by many extra-pituitary sites, including 
the immune cells (Ben Jonathan et al., 1996; Matera et al., 2000; De Bellis et al., 2005; 
Malaguarnera et al., 2005).  Chikanza and Grossman (1998) categorized prolactin as a pro-
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inflammatory neuropeptide, capable of modulating immune and inflammatory responses.  
Prolactin, released by both the pituitary gland and by some types of lymphocytes, exerts its 
influence on the immune system by endocrine and paracrine/autocrine mechanisms (Matera et 
al., 2000; DeBellis et al., 2005).   
 Proof of specific involvement of prolactin in the immune system comes from animal 
models in which pituitary deficiency was experimentally induced by surgical ablation of the 
gland or treatment with bromocriptine (Hiestand et al., 1986; Russell et al., 1988).  In both 
studies, lympho-hemopoietic function was restored when either prolactin was injected or a 
syngenic pituitary gland was implanted under the kidney capsule (Matera et al., 2000).  Other 
research by Rettori et al. (1994) showed that LPS altered the release of pituitary hormones in 
rats, increasing prolactin release and decreasing growth hormone, thyroid-stimulating hormone, 
and luteinizing hormone release.  More recently, Mastronardi et al. (2001) suggested that LPS 
acts on the central nervous system to inhibit the secretion of dopamine, removing the dopamine 
inhibition on the secretion of prolactin.  Consequently, the secretion of prolactin is increased 
from the lactotropes.   
Mastronardi et al. (2000) reported that prolactin stimulated leptin release, and that 
bromocriptine decreased plasma leptin concentrations.  Circulating prolactin, acting on its 
receptors on the adipocytes, increases the release of leptin that is stored in pinocytotic vesicles in 
the cytoplasm adjacent to the cell membrane.   The blocking of prolactin by bromocriptine 
produced a rapid and long-lasting lowering of plasma leptin concentrations.  The authors 
concluded that an increase in prolactin secretion during the night may be responsible, at least in 
part, for the nocturnal elevation of leptin concentrations observed in rats and in humans.   
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Gualillo et al. (1999) reported that several pro-inflammatory cytokines, most notably 
TNF-α and IL-1, both induced by prolactin, produce a prompt and dose-dependent increase in 
serum leptin levels and leptin mRNA expression in mice adipose tissue.  However, the 
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Research in swine (Estienne et al., 2000), sheep (Delavaud et al., 2000), cattle (Delavaud 
et al, 2002), and horses (Buff et al., 2002; Gentry et al., 2002) showed that concentrations of 
plasma leptin increase as animal fat mass increases.  In general, obesity is a leptin-resistant state 
in that higher leptin concentrations are found in more obese individuals (Mantzoros et al., 2000).  
However, Gentry et al. (2002) concluded that although leptin concentrations are very low in 
mares with low BCS and higher in well-fed mares, there is a wide variation in leptin levels 
among well-fed mares.  Subsequent research by Cartmill et al. (2003) indicated that horses with 
high BCS could have resting plasma leptin concentrations ranging from low (1 to 5 ng/mL) to 
very high (10 to 50 ng/mL).  Cartmill et al. (2003) further reported that the high vs.  low leptin 
distinction was consistent over a 2-yr period, indicating that the underlying cause was likely a 
permanent trait.   
Inadequate nutrition and/or reduced body fat are associated with impaired reproductive 
efficiency in beef cattle (Selk et al., 1988; Schillo et al., 1992) and sheep (Schillo, 1992).  A 
similar relationship has been noted for horses (Henneke et al., 1983; Gentry et al., 2002).  
Nutritionally restricted broodmares sometimes exhibit abnormal estrous cycling and may be 
difficult to breed successfully.  Research conducted by Gentry et al. (2002) revealed that low 
BCS and low plasma leptin concentrations were associated with inactive ovaries during winter 
and early spring; mares with low BCS eventually ovulated in April and May, even while leptin 
concentrations remained low. 
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During pregnancy, serum leptin concentrations increase in horses and humans, and drops 
sharply after delivery (Heidler et al., 2003).  In a low leptin environment, GnRH release is 
decreased, possibly to prevent energy from being wasted for reproduction (Caprio et al., 2001) or 
to encourage a faster increase in feed intake to prevent a negative energy balance (Block et al., 
2001).  Although short-term reductions in plasma leptin concentrations are not associated with 
changes in the reproductive axis in mares (McManus and Fitzgerald, 2000), prolonged exposure 
to lower leptin concentrations would be expected to decrease GnRH release (Yu et al., 1997).   
In contrast, chronically persistent hyperleptinemia can interfere with gonadotropin 
stimulation of peripheral targets.  In obesity, leptin central receptors, which are sensitive to 
extremely low ligand concentrations, are protected from hyperleptinemia by the saturable 
transport system of the blood-brain barrier, whereas peripheral leptin receptors are directly 
exposed to high ligand concentrations, with possible negative effects on gonadal steroidogenesis 
(Caprio et al., 2001). 
Leptin stimulates GnRH from the hypothalamus, which in turn stimulates LH and FSH 
from the anterior pituitary gland (Yu et al., 1997).  Although it was originally thought that leptin 
affected reproduction by regulating the hypothalamic-pituitary-gonadal axis, recent in vitro 
observations indicated that leptin may also have direct intra-ovarian actions (Mantzoros et al., 
2000).   In vitro bovine studies showed that leptin at high doses (300 ng/mL) weakly inhibited 
LH-induced androstenedione production (Spicer et al., 2000).  More recent research (Spicer, 
2001) indicated that in a high leptin environment, the ovary is kept from over-producing 
estradiol via leptin inhibition of insulin-induced androstenedione production by bovine thecal 
cells and aromatase activity by bovine granulosa cells in vitro.  Greisen et al. (2000) suggested 
that leptin acts directly to inhibit basal and FSH-stimulated estradiol and progesterone production 
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in cultured human granulosa cells.  These results introduce the possibility that high circulating 
leptin levels, as seen in obese women and mares, may compromise fertility through peripheral 
mechanisms.  If persistently high concentrations of leptin interfere with the development of the 
dominant follicle’s ability to produce estradiol, such an effect could result in an inadequate 
stimulus for the LH surge.   
Given the possibility that different concentrations of leptin exert both inhibitory and 
stimulatory actions on the hypothalamic-pituitary-gonadal axis, the present two studies were 
performed to examine further the possible role of hyperleptinemia on the re-breeding capabilities 
of mares and the relationship between leptin levels in lactating and non-lactating mares.  The 
specific objectives were 1) to determine the prevalence of high leptin secretors, as described by 
Cartmill et al. (2003), in postpartum, lactating mares and to evaluate any consequence of high 
versus low leptin levels on re-breeding capabilities, and 2) to examine possible relationships 
among BCS, age of mare, breed, feeding regime and reproductive history with plasma leptin 
concentrations in lactating mares and compare them with those in non-lactating mares.   
Materials and Methods 
Study 1.  A total of 198 light-horse and draft-type postpartum mares residing at eight 
individual and independent horse-breeding farms within Louisiana were used in this study. 
Mares were sampled during the month of April. Breeds represented were Quarter Horses (n = 
72), Thoroughbreds (n = 86), draft-type (n = 18), and warm-bloods (n = 24).  The mares were 
grouped into finite age groups: less than 6, 7 to 15, and over 15 yr of age, and were assigned to 
one of two groups based on their plasma leptin concentrations: low to normal leptin (< 10 
ng/mL) or hyperleptinemic (> 10 ng/mL).  The origin of the data used for this assignment is 
described below. 
 44
Information provided by each farm included breed, mare age, feeding schedule, type of 
feed, medical treatments, number of years the mare had been bred, number of live foals, and last 
foaling date.  A confirmation of pregnancy (or lack of pregnancy) was provided by each farm 
after the breeding season had concluded.  Body condition score was determined directly on each 
mare by one technician by visual appraisal and palpation of the six areas described by Henneke 
et al. (1983).  This was done at the time of the first blood sampling for each mare. (Table 3.1). 
For assessment of leptin status, two samples of jugular blood were collected from each 
mare approximately 2 wk apart.  The samples were collected in the morning (before 0900) by 
 
Table 3.1.  Breed prevalence, feeding regimen, mean mare and foal ages, mean body 
condition scores, and mean leptin concentrations for mares on the eight farms throughout 
Louisiana in Experiment 1  
Farm QHa  TBa WBa Da Feedingb 
Mare 
Age, yr 
 Foal  
Age, d BCS 
Leptin, 
ng/mL 
1 1 3 24 6 A 6 42 6.5 2.55 
2 0 14 0 2 B 9 39 5.5 3.19 
3 16 0 0 0 C 8 44 5.0 3.72 
4 7 0 0 0 B 11 64 5.0 3.87 
5 9 0 0 0 A 7 54 5.5 3.93 
6 45 0 0 0 B 11 54 5.5 4.47 
7 7 1 0 0 B 13 46 5.0 4.77 
8 0 54 0 9 B 9 37 5.5 7.28 
aQH = Quarter Horse; TB = Thoroughbred; WB = Warmblood; D = Draft Horse. 
bFeeding regimen: A = fed concentrate once per day plus pasture; B = fed concentrate 




jugular venipuncture into 7-mL evacuated tubes containing sodium heparin (Vacutainer, Becton 
and Dickinson, Franklin Lakes, NJ).  Previous studies of leptin in horses (Cartmill et al., 2003, 
2005; Crowley et al., 2005; Storer et al., 2005) revealed that leptin concentrations rise about 8 to 
10 h after a meal, thus morning samples would represent a non-stimulated state in the case of 
mares fed once per day (morning).  Also, the hyperleptinemic condition persists in the long-term, 
literally year-to-year in most cases.  Thus, to be considered hyperleptinemic, the leptin 
concentrations in both samples were averaged so that no one sample would determine the status 
of the mare. 
All blood samples were placed on ice and transported to the laboratory for analysis.  They 
were centrifuged at 1,500 x g at 4º C for 15 min and the plasma harvested and stored at -15º C.  
Plasma leptin concentrations were determined by means of a double-antibody leptin 
radioimmunoassay procedure described by Cartmill et al. (2003).  Estimates of the intra- and 
inter-assay CV averaged 6% and 4%, respectively.  Sensitivity of the leptin assay, based on a 
200-μL sample size, was 0.1 ng/mL (Cartmill et al., 2003).  Concentrations of progesterone were 
determined by radioimmunoassay with commercially obtained reagents (Diagnostic Laboratory 
Systems, Webster, TX, USA).  Intra- and inter-assay coefficients of variation and assay 
sensitivities for progesterone were 5%, 9%, and 0.05 ng/mL, respectively. 
 Data were analyzed by the SAS Proc Mixed procedure (SAS Institute, Inc., Cary, NC.).  
All factors were included in the model: breed, farm, day, body condition score of the mare, age 
of the mare, progesterone concentrations, feeding schedule, type of feed, medical treatments, 
number of years the mare had been bred, number of live foals, and last foaling date.  
Insignificant factors were removed one at a time to simplify the model, using a backward 
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elimination stepwise regression analysis.   The factors of interest in the final model were breed, 
farm, and BCS of mare.  The SAS Logistic Regression procedure (SAS Inst.  Inc., Cary, NC) 
was used to determine whether leptin levels affected the re-breeding of the mare. 
Study 2.  For comparison with the lactating mare data obtained in Study 1, data were 
collected within the same time period from 31 non-foaling, non-lactating mares of light horse 
breeds from the resident herd at the Louisiana Agricultural Experiment Station Horse Farm.  
Mares were housed on pasture of native grasses during the late spring, summer, and early fall, 
and on winter ryegrass pasture during the colder months of the year.  Mares were grouped by age 
and leptin status, and were assigned a BCS, as described for Study 1. 
Data were analyzed by the SAS Proc Mixed procedure (SAS Institute, Inc., Cary, NC.).  
The factor of interest in the final model was BCS of mare.   
Results 
Study 1.  A scatterplot of the data from the two samples for each mare is presented in Figure 3.1.  
The trendline (Y = 0.89X + 0.37) showed a positive and strong correlation ( R² =0.826).  Based 
on these data, it was decided to average the two leptin samples and to not use day as a repeated 
measure in the analyses. 
 Mean leptin concentration of the 198 lactating mares was 4.8 ng/mL, with a range of 
0.41 ng/mL to 14.9 ng/mL.   A frequency diagram, with mean leptin values categorized at 0.6 
ng/mL intervals, is shown in Figure 3.2.  There was an apparent normal distribution of mares 
around a mean of approximately 3 ng/mL, and another grouping of mares on the high end of the 
scale, around 10 ng/mL and greater.  Based on the 10 ng/mL cutoff, 26 mares (13%) were 


















Figure 3.1.  Leptin in the two morning blood samples 1 vs. 2.  The R² value for the regression 





















Figure 3.2.  Frequency diagram for mean leptin concentration.  Mares with mean concentration 























































































The mean BCS of the lactating mares was 5.5, with a range of 3.0 to 7.5 (Figure 3.3).  
Scores appeared to be normally distributed.  The BCS of the mare had a significant effect on 
leptin levels (P = 0.08), with leptin levels increasing in general as BCS increased (Figure 3.4).   
Feeding regimen affected leptin levels (P < 0.0083).  Compared to mares strictly on 
pasture, mares fed once each morning and on pasture otherwise had the lowest leptin 
concentrations; the morning and evening-fed mares displayed intermediate leptin levels (Figure 
3.5).   
Farm was also a significant source of variation for leptin levels (P < 0.0001).  Farm 1 
mares had the lowest leptin levels; those mares were meal-fed once a day.  Farm 8 had the 























Figure 3.3.  Frequency diagram for body condition score.  There were no mares with condition 
scores < 3 or > 7.5 (on a scale of 1 = emaciated and 9 = grossly obese). 
 
 
























Figure 3.4.  Leptin as a function of body condition score.  The numbers of mares per BCS are 



















Figure 3.5.  Feeding regimen affected leptin levels. Compared to the mares on pasture, the 
morning-fed mares had the lowest leptin concentrations, with the morning and evening-fed 
mares intermediate (n = 198; P < 0.0083).   
 



























































Figure 3.6.  Farm was a significant source of variation for leptin concentrations (P < 0.0001).  
The eight farms were ranked from the lowest to the highest leptin concentrations. 
 
Of the 198 lactating mares that were re-bred, 162 mares (81%) became pregnant.  The 
percentages for hyperleptinemic (81.34) and normal mares (81.44) were virtually identical 









Figure 3.7.  Percentage of mares pregnant at the end of the breeding season.  Leptin status 





































Study 2.   A scatterplot of the data from the two samples for each mare is presented in 
Figure 3.8.  The trendline (Y = -0.298 + 1.04X) showed a positive and strong correlation, with R² 
= 0.857. 
The mean leptin level of the non-lactating mares was 7.5 ng/mL, with a range of 2.3 
ng/mL to 20.2 ng/mL.  Of the 31 mares sampled, 9 mares (29%) displayed hyperleptinemia, with 
plasma leptin concentrations above 10 ng/mL.  The mean leptin level of the hyperleptinemic 
mares was 13.9 ng/mL.   
The mean BCS of the non-lactating mares was 7.5, with a range of 5.5 to 9.0.  BCS of the 
mare had a significant effect on leptin concentrations (P = .02), as leptin levels increased as BCS 

















Figure 3.8.  Leptin samples 1 vs. 2. Leptin concentrations (ng/mL) in jugular blood samples 
collected approximately 2 wk apart.  The R² value for the regression equation was 0.857. 
 
 































Figure 3.9.  Body condition scores for non-lactating mares relative to leptin levels. Leptin levels 
increased (P = .02) as BCS increased (n = 31). 
 
 
When the data were analyzed by the SAS Frequency Procedure, the chi-square tests of 
independence between BCS and leptin were of particular significance (P < 0.0001), indicating 
that within this group of mares, leptin concentrations were more affected by BCS than the group 
of lactating mares in Study 1.   
Discussion 
Contrary to human studies (Licinio et al., 1998; Caprio et al., 2001), recent research by 
Buff et al. (2005) showed that leptin in horses is not secreted in a pulsatile manner.  However, 
further studies have shown that a circadian pattern in the horse does exist, with leptin 
concentrations increasing during the night (Cartmill et al., 2005; Buff et al., 2005).  Further 
research with horses (Steelman et al., 2006; Cartmill et al., 2003) indicated that feeding 


















fluctuations in leptin production over a 24-h period.  Additional observations have indicated that 
plasma leptin concentrations increase postprandially in the equine (Cartmill et al., 2005; Crowley 
et al., 2005; Storer et al., 2005), perhaps stimulated by a rise in plasma insulin concentrations.  
To avoid possible discrepancies in sampling, the blood samples in the present two studies were 
obtained before the morning feeding. 
Average leptin levels from the Study 1 lactating mares were 4.8 ng/mL, while the average 
leptin levels from the Study 2 non-lactating mares was 7.5 ng/mL.  This discrepancy between 
experiments is consistent with recent studies (Heidler et al., 2003), which indicated that plasma 
leptin concentrations decrease after foaling and for 4 wk are lower in lactating than in non-
lactating mares.  A reduction in plasma leptin concentrations in lactating mares is also in 
agreement with findings in dairy cattle (Block et al., 2001; Heidler et al., 2003).  Block et al. 
(2001) reported that the plasma concentrations of leptin in dairy cows is reduced by ~50% after 
parturition, and remains depressed during lactation, despite a gradual improvement in energy 
balance.  The authors suggested that this reduction could benefit early lactating dairy cows by 
promoting a faster increase in feed intake and by diverting energy from non-vital functions such 
as reproduction.     
Considering leptin at high physiologic doses (>10 ng/mL), out of the 198 lactating mares 
sampled in Study 1, only 26 mares had leptin levels above 10 ng/mL.  The average leptin 
concentration from the 26 high leptin mares was 12.2 ng/mL.  Nine non-lactating mares from 
Study 2 had leptin levels above 10 ng/mL.  The average leptin concentration from the nine high 
leptin mares was 13.9 ng/mL.  This finding from Study 2 is consistent with previous research, 
which showed that within this particular resident mare herd, approximately one-third of the 
mares with high body condition scores consistently displayed high leptin concentrations, relative 
 54
to their herd mates (Gentry et al. 2002).  Subsequent monitoring of these hyperleptinemic mares 
and their herd-mates up to 2 yr later indicated the same high versus low leptin concentration 
distinction.   
Mares in the two studies had comparable ages, with most mares in the 7-15 year range.  
Previous studies (Buff et al., 2002; Kearns et al., 2006) have reported lower leptin values for 
younger mares and weanling fillies than mature mares.  Weanling fillies had significantly lower 
plasma leptin concentrations than mature mares (Kearns et al., 2006).  Buff et al. (2002) 
concluded that young horses are in the growth phase of development; thus, lower concentrations 
of leptin would be indicative of an animal with lower body fat and thus requiring greater 
nutritional resources.  Additionally, the mature mares used in the above studies (Buff et al., 
2002; Kearns et al., 2006) were non-lactating mares.  Older, lactating mares might be expected to 
have lower leptin levels to prevent a stimulation of the hypothalamic-pituitary-gonadal axis, 
which would allow the mare to more fully recover from the demands of parturition and lactation.  
However, within our study there were not a sufficient number of aged mares to compare.  These 
data are consistent with more recent research by Ferreira-Dias et al. (2005), who reported no 
significant difference between the plasma leptin concentrations of younger mares and older 
mares.   
In both studies, the effect of body condition scores on leptin levels indicated that as BCS 
increases, leptin levels increase.  The average BCS of the lactating mares was 5.5, while the BCS 
of the nonlactating mares was 7.5.  These results support previous research with horses (Buff et 
al. 2002; Gentry et al., 2002; Ferreira-Dias et al., 2005; Kearns et al., 2006) indicating that body 
weight has a direct relationship with plasma leptin levels.  The higher BCS of the mares in Study 
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 2 might be explained by the good body condition initially presented by the mares, in 
combination with no body weight fluctuations due to gestation, parturition, or demands of a foal.   
In high-yielding dairy cattle, the energy loss through lactation cannot be compensated by 
food intake during the first weeks of lactation.  Cows are in a constant state of negative energy 
balance; fat stores are first used for lactation, maintenance, and growth with reproductive 
processes receiving the lowest priority (Liefers et al., 2003).  The resulting negative energy 
balance is reported to delay the occurrence of ovarian cyclicity.  Reduced concentrations of 
peripheral IGF-I and estradiol are associated with ovulation failure during the first follicular 
wave postpartum in non-cystic dairy cows (Beam et al., 1999).   
In contrast to cattle, most lactating mares resume follicular growth and ovulation in early 
postpartum (Ginther, 1993), and ovulation is not impeded by suckling or the presence of a foal. 
The majority of foaling mares show estrous behavior and ovulate within 15 d after foaling 
(Neuschaefer et al., 1990), therefore lactational anestrous does not exist as a principal 
physiological condition in the horse (Heidler et al., 2004).  Lactation, on average, is not 
associated with weight loss in mares, as the mare seems able to compensate energy losses mainly 
by increasing feed intake, rather than by mobilization of body reserves.  Recent research by 
Heidler et al. (2004) suggested that a negative energy balance during lactation in most horse 
breeds may be prevented by adequate feeding.  The reduced leptin concentrations in postpartum 
mares may therefore encourage feed intake, which would allow the lactating mare to avoid an 
energy deficit.  The feeding regime at each stud farm was adequate; therefore, a negative energy 
balance was not evident in any of the mares studied.   
Adipocytes have been shown to be a major source of leptin in the body, but leptin 
synthesis has also been demonstrated in ovarian granulosa cells (Bützow et al., 1999).  Research 
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reported that leptin is present in follicular fluid, and the leptin receptor is expressed in the human 
ovary (Greisen et al., 2000; Mantzoros et al., 2000).  More recent research suggests that 
identification of Ob-R expression in the ovary may cause leptin to have a direct effect on 
downstream endocrine targets of the reproductive axis (Caprio et al., 2001).  In vitro studies with 
rats (Zachow and Magoffin, 1997; Zachow et al., 1999), porcine (Gregoraszczuk and Ptak, 
2005), bovine (Spicer and Francisco, 1997), and human (Agarwal et al., 1999) ovarian cells have 
demonstrated that leptin can exert direct inhibitory effects on steroidogenesis in granulosa cells 
and thecal cells obtained from developing follicles.  Overall, these data suggest that high leptin 
concentrations in the ovary may negatively control estradiol production and interfere with the 
development of dominant follicles and oocyte maturation. 
Graafian follicles are capable of concentrating steroids and gonadotropins in the follicular 
fluid.  Certain molecules present in serum are excluded from the follicular fluid, leading to the 
conclusion that the follicular fluid is a semi-protected environment (Agarwal et al., 1999).  When 
a follicle is selected to become dominant, FSH bioactivity in the follicular fluid begins to 
increase.  High physiological concentrations of leptin could significantly interfere with the 
ability of the dominant follicle to produce estradiol.  Such an effect could result in an inadequate 
stimulus for the LH surge and may also lead to an immature pre-ovulatory follicle, or in extreme 
cases, no pre-ovulatory follicle at all.  This type of mechanism is consistent with clinical 
observations that obese women have a higher incidence of infertility and that weight loss often 
causes significant clinical improvement (Kiddy et al., 1992; Bützow et al., 1999; Caprio et al., 
2001). 
Leptin, alone, has no effect on gonadotropin-stimulated steroidogenesis, but leptin is a 
potent inhibitor of the insulin-like growth factor IGF-I augmentation of gonadotropin action in 
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rat and bovine cells (Spicer, 2001).  Agarwal et al. (1999) reported that in human cultured 
granulosa cells, leptin had no effect on estradiol production, either alone or in the presence of 
FSH.  However, leptin in humans did cause a concentration-related inhibition of the IGF-I 
augmentation of FSH-stimulated estradiol production.  The effect of leptin was specific, because 
there was no effect on progesterone production.  In cultured human theca cells, leptin did not 
alter androstenedione production, either alone or in the presence of LH.  However, leptin caused 
a concentration-related inhibition of the IGF-I augmentation of LH-stimulated androstenedione 
production.  Additional research (Bűtzow, et al., 1999) supported the notion that leptin may 
inhibit the synergistic action of IGF-I and FSH on granulosa cell estradiol production.  Leptin 
synthesis has been expressed in ovarian granulosa cells; therefore Bűtzow et al. (1999) suggested 
that the inhibitory action of leptin in the ovary may partially explain why obese individuals 
require higher doses of gonadotropin for ovarian hyperstimulation. 
Research by Heidler et al., (2003) reported that plasma leptin concentrations decrease 
after foaling, and for 4 wk plasma leptin concentrations were lower in lactating than in non-
lactating mares (P < 0.05).  Although short-term reductions in plasma leptin concentrations are 
not associated with changes in the reproductive axis in mares (McManus and Fitzgerald, 2000), 
prolonged exposure to lower leptin concentrations would be expected to decrease GnRH release 
(Yu et al., 1997).  The reduced leptin concentrations may promote feed intake and allow lactating 
mares to avoid an energy deficit.  Previous research (Hess-Dudan et al., 1994) reported that in 
mares, concentrations of IGF-I increased during late pregnancy, peaked two days after 
parturition, and declined gradually until weaning.  More recent research (Heidler et al., 2003) 
confirmed that IGF-I concentrations increased continuously in late gestation, reached a 
maximum in the week of foaling, and decreased thereafter during lactation.   
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Consequently, in a low leptin, high IGF-I postpartum in vivo environment, leptin would 
not be able to inhibit the IGF-I augmentation of FSH-stimulated estradiol production.  Therefore, 
resumption of ovarian activity by the lactating mare is resumed during early postpartum and 
most mares will ovulate reliably in foal heat.  Out of the 199 mares from Study 1 that were re-
bred, 162 mares (81%) became pregnant.  However, no significant difference was found between 
the re-breeding capabilities of a high leptin mare versus a low leptin mare.  Our results are 
consistent with more recent research from our laboratory (Waller et al., 2006), which suggested 
that the reproductive system in the mare appears to be unaffected by the changes in leptin.  
Waller et al. (2006) reported that the mares studied had no apparent alteration in reproductive 
characteristics: ovarian activity, day of ovulation; gonadotropin and progesterone concentrations 
were similar for mares of high BCS with high versus low leptin concentrations.   
Due to the fact that the non-lactating mares were not bred, a direct comparison between 
these two experiments cannot be made.  However, these results concerning BCS with leptin 
levels are consistent with previous research, in that with an increase in BCS, leptin levels also 
increase.  These results are consistent with research showing that postpartum mares have lower 
leptin levels.   
It is likely that within the various sites of leptin action, a specific and narrow range of 
leptin concentration must be maintained for normal hypothalamic-pituitary-gonadal function, 
with chronic deviations interfering with the hypothalamic-pituitary-gonadal axis.  Additionally, 
research supported the finding that leptin by itself is not the sole determinant of reproductive 
activity.  The lactating mares were well cared for on each stud farm, so no mares with 
chronically low leptin levels were nutritionally deprived.  Although the mean leptin level and 
BCS for the lactating mares was much lower than the non-lactating mares, this concentration 
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apparently was within the threshold for reproductive success.  For the 37 mares that did not re-
breed, chronically low or high leptin levels cannot be considered as the reason.  Furthermore, the 
11 hyperleptinemic lactating mares were also within their threshold for reproductive success.  
For leptin to have a negative effect on the gonadal steroidogenesis of these hyperleptinemic 
mares, the expected threshold would have to exhibit leptin levels persistently higher than 11 
ng/mL.   
It may be hypothesized that a specific and narrow range of leptin concentrations is 
necessary to maintain a normal reproductive function, and that concentrations below or above 
these thresholds might interfere in opposing ways with the function of the HPG axis (Caprio et 
al., 2001).  However, to assign a global threshold number for infertility would be unrealistic.  
The high and low boundaries would likely be on an individual basis, due to the complex 
interaction with other molecules such as hormones, growth factors, and cytokines.   
Mantzoros et al., (2000) found that women who succeeded in becoming pregnant with 
artificial reproductive techniques had significantly lower leptin concentrations in follicular fluid, 
when compared with women who failed to become pregnant.  Future research would determine 
whether there are significant differences between serum leptin and follicular fluid leptin, and 
whether the functional state of the ovary might affect serum leptin concentrations.  Direct 
measurement and interactions of other follicular fluid hormonal factors, such as androgens, 







SEARCH FOR POLYMORPHISM IN EXON 2 




 Obesity, a growing dilemma within the horse industry, is associated with numerous 
medical conditions.  These conditions include chronic laminitis (Buff et al., 2002; Johnson, 
2002), hyperinsulinemia, glucose intolerance (Johnson, 2002; Cartmill et al., 2003), and 
variations in thyroid hormone concentrations (Cartmill et al., 2003).  The leptin-signaling 
pathway may play an important role in the pathophysiology of the obese condition. Leptin 
appears to modulate feeding behaviors and energy expenditure, and therefore plays an important 
role in body weight regulation (Henson and Castracane, 2003). 
Leptin is expressed primarily in the white adipocytes; both its expression and its secretion 
are highly correlated with body fat and adipocyte size (Henson and Castracane, 2003; Paracchini 
et al., 2005).  The primary factors affecting plasma leptin concentrations include body fat mass 
and energy balance (Block et al., 2001) and gender (Henson and Castracane, 2003).  Plasma 
leptin levels in dairy cattle and sheep increase linearly with increased body fat mass and plane of 
nutrition (Blache et al., 2000; Delavaud et al., 2000; Ehrhardt et al., 2000), and these results are 
consistent in humans and rodents (Henson and Castracane, 2003).  
Previous work focusing on the interaction between BCS and leptin concentrations in 
horses indicated that a wide variation in leptin values in well-fed horses revealed some other 
factor besides body condition affecting leptin concentrations.  Polymorphisms in the leptin gene 
might possibly modify obesity.  A mutation in the mouse LEP gene was first described by Ingalls 
et al. (1950).  Zhang et al. (1994) later described the ob mutation as a cytosine (C) to thymine (T) 
substitution at codon 105, which results in a premature stop codon.  Therefore, leptin production 
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stops.  This mutation results in a total lack of leptin in the blood, which results in obesity, 
hyperphagia, hypothermia, extreme insulin resistance, and infertility in the ob/ob mouse 
(Paracchini et al., 2005).  Four genetic polymorphisms found in the porcine leptin gene were 
associated with fatness in four pig breeds (Jiang and Gibson, 1999).  Subsequent research, 
however, indicated that the four polymorphisms are generally of low frequency or are absent in 
pig populations (Kennes et al., 2001).  A polymorphism within exon 2 of the bovine leptin gene 
has been described (Pomp et al., 1997; Fitzsimmons et al., 1998; Haegeman et al., 2000) and is 
associated with fat deposition in beef cattle (Fitzsimmons et al., 1998).  Researching beef breeds, 
Buchanan et al. (2001) reported a cytosine (C) to thymine (T) nucleotide base transition that 
encoded an amino acid change of an arginine to a cysteine in exon 2 of the bovine leptin gene.  
The T allele was associated with fatter carcasses, while the C allele was associated with leaner 
carcasses.  More recent research by Buchanan et al. (2003) revealed the same genetic variant 
present in dairy breeds.  Dairy cows homozygous for the T allele produced more milk, without 
any significant alteration in milk fat or protein percent, over the entire lactation. 
The aforementioned experiments provide evidence that leptin is a credible candidate gene 
for the evaluation of polymorphisms that could have an effect on equine obesity. The aim of the 
present experiment was to investigate the possible occurrence of an analogous single nucleotide 
polymorphism (SNP) in exon 2 of the equine leptin gene that would explain the wide variation of 
leptin levels in high BCS mares. 
Materials and Methods 
Phase 1.  Horses and Sampling Procedures.  All horses were of light breeds from the 
resident herd at the Louisiana Agricultural Experiment Station, Central Stations Horse Farm.  
The horses were routinely maintained on native grass pastures during the spring, summer, and 
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fall and on ryegrass pasture in winter.  Leptin, age, and BCS data were compiled over a 2-yr 
period on a total of 31 mares, 16 geldings,  and 11 stallions. Each year a BCS, as described by 
Henneke et al (1983; 1= extremely emaciated through 9 = extremely fat), was assigned to each 
horse by two independent, experienced technicians; the mean of the two scores was used for 
statistical analyses.  Jugular blood samples were collected from each horse into heparinized tubes 
for determination of plasma leptin concentration.  
Laboratory and Statistical Analyses.  Jugular blood samples were immediately 
centrifuged at 1,500 x g at 5º C, and the plasma was harvested and stored at -15º C.  
Concentrations of leptin were measured using the double-antibody leptin radioimmunoassay 
procedure described by Cartmill et al. (2003).  Estimates of the intra- and inter-assay CV 
averaged 6% and 4%, respectively.  Sensitivity of the leptin assay, based on a 200-μL sample 
size, was 0.1 ng/mL.  Data were analyzed by the Proc Mixed procedure of SAS (SAS Institute, 
Inc., Cary, NC.).  All factors (age, gender, BCS, and all possible interactions) were initially 
included in the model.  The results of the model with the log transformed leptin values and all 
possible interactions showed that none of the interactions were significant.  Therefore, the model 
was subsequently run with just the main effects (gender, BCS, and age).   
Phase 2.  Purification of DNA.  A jugular venous blood sample was collected from one 
hyperleptinemic mare into an evacuated tube (Becton and Dickinson, Franklin Lakes, NJ) 
containing lithium heparin.  Genomic DNA was extracted from the white blood cells and 
purified, using the PUREGENE DNA Purification Kit (Gentra Systems, Inc. Minneapolis, MN).  
Forward and reverse primers were designed based upon the nucleotide sequences of the Bos 
taurus leptin (obese) gene (GenBank Accession # U50365).  
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The Forward primer was 5’-TATCTTGTCCTTCTTGCAGAGCTCT-3’ (bp 217-241). 
The Reverse primer was 3’-GTCAGTCACAGTAGAAACAAAGCCAG-5’ (bp 3960-3985).  
Polymerase chain reaction (PCR) was performed to amplify the specific region of the equine 
leptin gene containing exon 2 and partial fragments of introns 1 and 2.  Amplifications via PCR 
were carried out in 50-µl reactions containing 5-µl genomic DNA, 1-µl of forward primer at 20-
µM concentration, 1-µl of reverse primer at 20-µM concentration, 1-µl 50X dNTP mix, 1-µl 
Advantage Genomic Polymerase Mix in 5-µl 10X Genomic PCR Reaction Buffer with 2.2-µl 
mM Mg(OAC)2 (CLONTECH Laboratories, Inc., Mountain View, CA).  The PCR was 
performed in a BioRad thermocycler (Bio-Rad Laboratories, Hercules, CA).  Thermal cycling 
parameters included an initial denaturation at 94º C for 1 min, followed by 30 cycles of 
denaturing at  94º C for 30 sec, and annealing at 68º C for 4 min.  A final extension at 68º C for 5 
min was performed to reduce background.   
Agarose Gel Electrophoresis.  Positive and negative samples were analyzed, along with a 
suitable DNA sized marker, by electrophoresis on agarose gel. The percentage of agarose used 
was 0.8%, with a voltage of 70V.  To avoid damage to the PCR product by UV light, a crystal 
violet agarose gel was used. The buffer was poured off of the gel and the gel was transferred to 
the UV photo machine where the band was carefully excised from the gel with a sharp razor 
blade.  Next, the excised PCR product was isolated. 
 Isolating the PCR Product. A SNAP (Invitrogen, Carlsbad, CA) purification column and 
collection vial was used for rapid purification of the DNA fragments from the agarose gel.  The 
final isolated DNA product was analyzed by electrophoresis on an agarose gel to estimate the 
DNA concentration.  Ethidium bromide was used in the agarose gel. 
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 Chemical Transformation and Cloning Reaction.  The gel-purified long PCR product was 
inserted into pCR®-XL-TOPO®  plasmid vector (Invitrogen) by topoisomerase I from Vaccinia 
virus.  Transformation of chemically competent E. coli with the plasmid DNA was 
accomplished, according to TOPO XL PCR Cloning Kit (Invitrogen).   After an overnight 
growth on plain nutrient lysogeny broth (LB) agar plates, selection of host cells harboring the 
recombinant DNA was performed by inoculating the cells in a very rich culture media Terrific 
Broth (TB) containing kanamycin, and incubating the cells overnight at 37º C with vigorous 
shaking. 
 Plasmid DNA Isolation, Analysis, and Sequencing.  The resulting DNA plasmid was 
enzymatically digested by restriction analysis to confirm the presence of the segment of interest 
of the leptin gene. Restriction enzymes EcoRI (sequence 5’- G^AATTC-3’) and Not1 (5’-
GC^GGCCGC-3’) were used.  The restriction fragments were amplified by PCR and the 
resulting PCR product was sequenced on an automated DNA sequencer using the M13 Reverse 
primer, which is  (5’-CAGGAAACAGCTATGAC-3’) and the M13 Forward primer, which is 
(5’-GTAAAACGACGGCCAG-3’).   
 Sequence of Exon 2 and Flanking Introns.  Using the leptin mRNA (GenBank 
AY462242), a partial sequence of the equine leptin gene, forward and reverse primers were 
designed to partially sequence intron 1 and intron 2.  Exon 2 is from bp 1-118; exon 3 is 119-
421. The forward primer (5’-CTGTGGCTTTGGCCCTATCTG-3’) is at bp 1 – 21, and the 
reverse primer, which is  (3’-ACTAGGACCACTGTTAGCAG-5’), is at bp 80 – 100 (Figure 
4.1).  Sequencing reactions were performed at the Louisiana State University School of 
Veterinary Medicine’s GeneLab, using Applied BioSystems BigDye Terminator version 3.1 







 1  ctgtggcttt ggccctatct gttcttcatt gaagctgtgc ccatccgaaa agtccaggat 
 
       61 gacaccaaaa ccctcatcaa gacgattgtc accaggatca atgacatttc acacacgcag 
 
      121 tcagtctcct ccaaacagag ggtcactggt ttggacttca ttcctgggct tcaccctgtc 
 
      181 ctgagtttgt ccaagatgga ccagacattg gcaatctacc aacagatcct tacaagtctg 
 
      241 ccttccagaa atgtgatcca gatatctaat gacctggaga acctccggga ccttctccac 
 
      301 ctgctggcct cctccaagag ttgccccttg ccccaggcca ggggtctgga gaccttggcg 
 
      361 agcctgggcg gtgtcctgga agcttcactt ctactccaca gaggtggtag ccctgagcag 
 
      421 gctgcagggg tctct 
 
 
Figure 4.1.  Equine leptin mRNA (GenBank AY462242).  Exon 2 (bp1-118) and exon 3 (bp119-
421).  Forward primer (5’-TGTGGCTTTGGCCCTATCTG-3’) is at bp   










Phase 3.  Single Nucleotide Polymorphism Assessment.  Five mares with the lowest 
leptin concentrations and five with the highest leptin concentrations, with a BCS of at least 7.5, 
were selected from the available mares in Phase 1 to study the prevalence of polymorphisms in 
exon 2 of the equine leptin gene.  A jugular blood sample was collected from each mare into a 
tube containing lithium heparin.  Genomic DNA was extracted from the white blood cells of 
each mare and purified, using the PUREGENE DNA Purification Kit as described in Phase 2.  
Purified DNA samples were then quantified by UV spectrophotometry to estimate their 
concentration and purity.  Forward and reverse primers were designed from the flanking introns 
of the genomic fragment that were isolated and sequenced in Phase 2.   The forward primer (5’-
CAGCGACTTGCAATGTATGG-3’) is located 16 bp upstream of the untranslated region 
(UTR) of exon 2.  The reverse primer (3’-TCTATGTGGGGTCCCAGTGT-5’) is located 18 bp 
downstream from the end of exon 2 (Figure 4.2).  The PCR was performed in a BioRad 
Thermocycler (Bio-Rad Laboratories, Hercules, CA), using the TOPO plasmid as the positive 
control.  The PCR amplifications were carried out using Platinum Taq DNA Polymerase 
(Invitrogen) in 50-μl reactions following the basic PCR protocol included in the kit.  The 
reaction contained 1-μl template DNA, 1-μl of forward primer at 20-μM concentration, 1-μl of 
reverse primer at 20-μM concentration, 1-μl Taq DNA Polymerase (5 U/μl), 1-μl 10mM dNTP 
mixture, 1.5-μl MgCl2 (50mM), and 5-μl 10X PCR Buffer, minus Mg. Thermal cycling 
conditions included an initial denaturation at 94º C for 2 min to completely denature the 
template, followed by 30 cycles of denaturing at  94º C for 30 sec,  annealing at 58º C for 30 sec, 







gcccaagaagcacatcctggaaggaa atg cac tgt gga ccc ctg tgc caa ttc 
   UTR               M   H   C   G   P   L   C   P   F 
 
ctg tgg ctt tgg ccc tat ctg ttc ttc att gaa gct gtg ccc atc cga aaa gtc cag gat 
 L   W   L   W   P   Y   L   F   F   I   E   A   V   P   I   R   K   V   Q   D 
 
                 
gac acc aaa acc ctc atc aag acg att gtc acc agg atc aat gac att tca cac acg  






Figure 4.2.  Forward and reverse sequencing primers. Forward primer (5’-
CAGCGACTTGCAATGTATGG-3’) is located in intron 1, 16 bp upstream of the untranslated 
region (UTR) of exon 2.  Reverse primer (3’-TCTATGTGGGGTCCCAGTGT-5’) is located in 
intron 2, 18 bp downstream from the end of exon 2.   
 
 
Agarose Gel Electrophoresis.  The samples were analyzed, along with a suitable DNA 
sized marker, by electrophoresis on a 1.2 % agarose EtBr gel. The voltage was at 80V.  The 
buffer was poured off of the gel and the gel was transferred to the UV photo machine, where the 
band was carefully excised from the agarose gel with a sharp razor blade.  
 Isolating the PCR Product.  The PureLink Quick Gel Extraction Kit (Invitrogen) was 
used for the purification of the DNA fragments from the agarose gel.  Purified samples were 
transported to the Gene Lab at Louisiana State University School of Veterinary Medicine for 
automated DNA sequencing.  Sequencing reactions were performed using Applied BioSystems 
BigDye Terminator version 3.1 chemistries on an Applied Biosystems Genetic Analyzer. 
 Computer-assisted Analysis. The Basic Alignment Search Tool (BLAST; Altschul et al., 
1990) was used to translate DNA sequences and to conduct homology searches of the protein 





Phase 1.  A positive correlation between leptin and BCS was detected (P = 0.0002), with 
leptin concentrations being greater in horses with higher body condition scores (Figure 4.3).  A 
positive correlation was also detected between leptin and gender (P = 0.015).  The geldings were 
significantly different than the mares (P = 0.005), but the stallions were not significantly 
different from either the geldings (P = 0.29) or the mares (P = 0.50).  The mean leptin value for 
the geldings was 3.6 ng/mL; for the mares, 7.6 ng/mL; and for the stallions, 5.6 ng/mL (Figure 




















Figure 4.3.  Relationship between serum leptin concentrations and BCS. Individual 























Figure 4.4.  Leptin concentrations in mares, stallions and geldings. The geldings were 
significantly different than the mares (n = 58; P = 0.005), but the stallions were not significantly 




Phase 2.  Exon 2 and partial sequences of intron 1 and intron 2 were sequenced.  Using 
the BLAST program (Altschul et al., 1990), our sequenced exon 2 was confirmed with published 
(partial) equine exon 2 (GenBank AY462242) and with the Bos taurus leptin (obese) gene 
(GenBank Accession # U50365).   Exon 2 and the junctions of intron 1 and intron 2 are shown 
(Figure 4.5).  There is a 26 bp UTR preceding the start codon of ATG in exon 2.  Splice sites at 















 gcccaagaagcacatcctggaaggaa atg cac tgt gga ccc ctg tgc caa ttc 
    UTR               M   H   C   G   P   L   C   P   F 
 
ctg tgg ctt tgg ccc tat ctg ttc ttc att gaa gct gtg ccc atc cga aaa gtc cag gat 
 L   W   L   W   P   Y   L   F   F   I   E   A   V   P   I   R   K   V   Q   D 
 
                 
gac acc aaa acc ctc atc aag acg att gtc acc agg atc aat gac att tca cac acg  









Figure 4.5. Exon 2 with partial sequence of flanking introns.  Splice sites obey the AG/GT 
consensus rule at the intron/exon boundaries. Twenty-six bp UTR before start codon of ATG. 
 
  
 The sequence was further compared through BLAST (Altschul  et al., 1990) with the 
Equus caballus whole genome (GenBank Accession # AAWR00000000).   The equine ob gene 
spans 14150 kilobases (kb) and is organized into one non-coding exon and two coding exons 
separated by two introns. Nucleotide frequencies are: A = 0.24; G= 0.26; T = 0.25; and C = 0.25.  
Exon 2 and exon 3 are coding exons with an open reading frame coding 167 amino acids. The 
non-coding Exon 1 is 29 bp in length. The first intron, 9118 bp in size, occurs after the non-
coding exon 1 in the 5’-untranslated region and ends 27 base pair (bp) upstream of the ATG start 
codon.  Exon 2 is 171 bp in length which includes a 26 bp 5’ UTR.  The start codon ATG  is 
followed by an open reading frame coding of 47 amino acids. The second intron of 1617 bp 
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begins after exon 2 and ends upstream of glutamine. Exon 3 is a coding exon with an open 
reading frame coding of 199 amino acids.   
 Comparative genomics was used to locate potential regulatory elements within the 5’ 
and 3’ flanking regions of the equine ob gene. The potential transcription initiation sites were 
mapped in the 5’-flanking region of the leptin gene.  A computer search of the 5’-flanking region 
for cis-acting regulatory elements revealed the presence of three copies of GC boxes (GGGCGG) 
a binding site for CCAAT/enhancer-binding protein (C/EBP) and an E box (CANNTG, N=G/T)  
(Prestridge, 1995).  A TATA box-like sequence (TATAAG) is located 30 bp upstream of exon 1.  
Splicing donor and acceptor consensus sequences were located at the putative exon/intron 
borders.  The predicted splice sites at the intron/exon boundaries were analyzed using the 
Softberry computer program (Softberry, Inc, Mount Kisco, NY).  At the intron/exon boundaries, 
splice sites obey the AG/GT consensus rule, as these dinucleotides are at the first two and last 
two positions of the introns.  The exon/intron borders were also determined by genomic 
comparisons through BLAST (Altschul et al., 1990) of the nucleotide sequences of the human, 
bovine and mouse ob gene (GenBank Accession No. U43653, U50365 and U18812 
respectively). 
The FGeneSH computer program (Softberry, Inc.) was used for predicting exon regions 
in the genomic DNA sequence; BLAST (Altschul et al., 1990) was also used to search for exons. 
Nucleotide identities of other species (Bos taurus, Homo sapiens, Mus musculus, Sus scrofa and 
Canis familiaris) were compared with the equine leptin gene by BLAST using NCBI genome 
databases.  The equine nucleotide sequence was 78 to 87% identical to the leptin nucleotide 
sequences of the above mentioned species.  The highest identity was found to mouse leptin 
(Table 4.1). 
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Table 4.1. Comparison of equine nucleotide sequence.  The equine nucleotide sequence 
was 78 to 87 % identical to leptin nucleotide sequences in other species.  The highest 
identity was found to mouse leptin 
 
Species    Identity % GenBank 
Bos Taurus 78 U50365 
Homo sapiens 78 U43653 
Mus musculus 87 U18812 
Sus scrofa 82 U63540 




The FGeneSH computer program (Softberry, Inc.) was used for the prediction of the 
polyadenylation signal.  The AAUAAA hexamer motif, the cleavage site (CA) and the GU-rich 
downstream element (DSE) was found.  The AAUAAA hexamer is positioned 20 bp upstream of 
the CA dinucleotide, which precedes the actual site of transcript cleavage.  A GU-rich element is 
positioned 26 bp downstream from the hexamer.  
Phase 3.  Based on the 10 mares tested herein, there does not appear to be a 
polymorphism in exon 2 of the equine leptin gene. The DNA sequences for all 10 mares were 
homologous; therefore, polymorphism is not a likely explanation for the high vs. low difference.  
Discussion 
 Results from Phase 1 indicated that gender and BCS significantly affect leptin 
concentrations in horses, whereas age does not.  These results regarding the effects of gender and 
age on leptin are inconsistent with previous research by Buff et al. (2002), who concluded that 
concentrations of leptin were greater in geldings and stallions than in mares, and tended to 
increase with the age of the animal. The discrepancy with regard to age may be due to the fact 
that the horses in our study ranged in age from 4 years to 23 years, while the horses in the Buff et 
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al. (2002) study ranged in age from 8 d to 24 yr.  Furthermore, Buff et al. (2002) reported that the 
greatest concentration of leptin was observed in horses greater than 12 yr old. The average age of 
horse in our study was 12 years; consequently, the majority of the horses would have passed 
their principal growth stages. Young horses are in the growth phase of development and thus 
lower concentrations of leptin would be indicative of an animal with lower body fat and 
requiring greater nutritional resources (Buff et al., 2002).  More recent research (Chapter 3 
herein) indicates no significant age effect on leptin levels.   
The effect of gender in Phase 2 data is consistent with research by Cartmill et al. (2003), 
who reported that mares had greater concentrations of leptin than geldings (10.4 ng/mL vs. 6.6 
ng/mL).  Moreover, the geldings in the Cartmill et al. (2003) study had an average BCS slightly 
higher than the mares, indicating even a lesser leptin output per unit of fat mass.  The mares and 
geldings in the present experiment both had similar BCS (7.0 and 7.5, respectively), while the 
stallions had an average BCS of 5.5.   As suggested by Henson and Castracane (2003), after 
accounting for body fat, the single most important determinant of serum leptin is gender, with 
more circulating leptin in women than men of equivalent body fat.  The authors (Henson and 
Castracane, 2003) proposed that the gonadal steroids are responsible for this gender dichotomy 
in serum leptin, influencing the site of fat deposition and directly acting on leptin synthesis in 
adipose tissue.  
These results regarding BCS and leptin were consistent with previous research showing 
that circulating leptin concentrations are generally correlated to body fat mass (Fitzgerald and 
McManus, 2000; Buff et al., 2002; Gentry et al., 2002; Cartmill et al., 2003).  As seen in Chapter 
3 herein, the relationship between BCS and leptin concentrations appears greatest in non-
lactating mares of high BCS and less evident in lactating mares.    
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 The leptin protein is highly conserved in molecular structure among species.  To further 
understand the physiologic and pathophysiologic roles of the equine leptin gene, it is important 
to clarify the structural organization of the gene (Isse et al., 1995). Comparative genomics was 
used to further identify and characterize potential regulatory elements in the 5’ and 3’ flanking 
regions of the equine leptin gene (BLAST, Altschul et al., 1990).  The potential structural 
organization of the equine leptin gene is reported herein, supported by EST and cDNA data from 
bovine, human, mouse, pig and dog species (GenBank Accession No.U50365, U43653, U18812, 
U63540, and AB020986, respectively)  and with data from the equine whole genome (GenBank 
Accession No. AAWR00000000).  Regulatory sites within the above mentioned orthologs 
showed significant correlations.  
One of the most common regulatory elements is the GC box, which is widely distributed 
in promoter regions of tissue-specific genes (Philipsen and Suske, 1999).  A computer search 
(PROMOTER SCAN, Prestridge, 1995) of the 5’-flanking region for cis-acting regulatory 
elements revealed the presence of three copies of GC boxes (GGGCGG). It was generally 
thought that Sp1 (named according to the original purification scheme that included Sephacryl 
and phosphocellulose columns) was the major factor acting through the GC box motif.  Recent 
discoveries determined that Sp1 is only one of many transcription factors binding and acting 
through these elements (Philipsen and Suske, 1999). 
  A TATA box-like sequence (TATAAG) is located 30 bp upstream of the exon 1.  A 
TATA box is considered to be the core promoter sequence in eukaryotes (Smale and Kadonaga, 
2003). 
A computer search (PROMOTER SCAN, Prestridge, 1995) of the 5’-flanking region also 
revealed the presence of an E box (CANNTG, N=G/T).  The cis-element E box is present in the 
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regulatory regions of many tissue-specific genes (Kim et al., 1995) and is the binding site for the 
basic-helix-loop-helix proteins (bHLH).  The E box is a highly conserved DNA element 
(CANNTG) recognized by the bHLH family of transcription factors, and acts as a cell type-
specific enhancer of class I promoter activity.  Precise DNA binding site selection by individual 
bHLH family members is determined both by the central dinucleotide contained in the core 
hexamer sequence and the flanking nucleotides (Howcroft et al., 1999).  The central dinucleotide 
found in the equine leptin gene E box is GT.  
One putative binding site for members of the CCAAT/enhancer-binding protein (C/EBP) 
family of transcription factors was identified immediately upstream from the TATA box 
(PROMOTER SCAN, Prestridge, 1995).  The observation that ob gene expression is positively 
influenced by C/EBPα is consistent with numerous studies showing the role of this transcription 
factor in adipogenesis and energy homeostasis (De La Brousse et al., 1996).  In mouse research, 
the C/EBPα transcription factor has been implicated as an indispensable transcriptional activator 
of adipocyte genes during preadipocyte differentiation.  The obese gene, like many other 
adipocyte genes, is most likely transcriptionally activated by C/EBPα during preadipocyte 
differentiation.  Expression of the mouse obese (ob) gene is immediately preceded by the 
expression of C/EBPα.  While the 5’ flanking region of the mouse ob gene contains several 
consensus C/EBP binding sites, only one of the sites appears to be functional (Hwang et al., 1996 
Further studies with the equine leptin gene are needed to elucidate the functional significance of 
this 5’ cis-acting regulatory element. 
Polyadenylation is one of the mRNA maturation steps in eukaryotic cells.  The 
AAUAAA hexamer is the almost invariant poly(A) signal that is positioned ~ 15 nt upstream of 
the site of cleavage.  The sequence AAUAAA is one of the most highly conserved sequence 
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elements known (Zhao, et al., 1999).  A poorly conserved GU-rich or U-rich element is usually 
positioned 20 – 30 nt downstream of the hexamer.  These two elements form the core poly(A) 
site (Klasens et al., 1998; Takagaki and Manley, 1997).  The cleavage site itself, which becomes 
the point of poly(A) addition, is determined mainly by the distance between the upstream 
AAUAAA sequence and the downstream elements (DSE).  A CA dinucleotide defines the 
poly(A) site for most genes (Zhao, et al., 1999).  We used comparative genomics to identify and 
characterize functional polyadenylation sites in the human, bovine, and equine leptin genes 
(BLAST, Altschul et al., 1990). To compare poly(A) sites located on ortholog gene pairs in 
human and bovine to equine, we aligned 3’ UTR regions of  the three leptin genes, and defined 
these as “conserved” poly(A) sites displaying aligned poly(A) signals. 
This study provides a better understanding of the molecular mechanisms underlying the 
leptin gene and should aid in leptin gene research within the equine species. Single gene 
polymorphisms resulting in obesity are very rare (Mergen et al., 2006), and therefore it appears 
more likely that a combination of polymorphisms in one or more candidate genes may contribute 
to the development of obesity.  Nevertheless, distinct differences in leptin secretion rates do 
indeed persist in a percentage of obese mares, and as Cartmill et al. (2003) reported, these 
differences are associated with perturbations in insulin, glucose, and thyroid hormone 
concentrations.  Based on the five high leptin and five low leptin mares tested, there was no 
apparent polymorphism in exon 2 of the equine leptin gene.  Therefore, polymorphism is not a 
likely explanation for the high versus low difference.  Larger studies, including testing of 
multiple genes in both obese and lean subjects, will likely be needed to better understand the role 
of leptin in regulating weight.  Because of the complex interaction with other molecules such as 
hormones, growth factors, and cytokines, future studies should also consider possible 
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interactions with other genetic polymorphisms.  Polymorphisms in the 5’ promoter region and 
exon 3 should also be considered.  The pathogenesis of obesity is complex and the interaction 
between the large number of both genetic and environmental factors needs to be considered. 
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CHAPTER 5 
ENDOCRINE RESPONSES TO ADMINISTRATION OF A LOW DOSE OF 
ENDOTOXIN LIPOPOLYSACCHARIDE IN MARES AND GELDINGS WITH HIGH 
VS. LOW PLASMA LEPTIN CONCENTRATIONS  
 
Introduction  
During periods of immune challenge, pro-inflammatory cytokines orchestrate a 
homeorhetic response within the body. Organisms respond to the inflammation by mounting a 
complex and coordinated sequence of events involving the immune, nervous, and endocrine 
systems in order to restore homeostasis (Spurlock, 1997). 
Leptin has been identified as a crucial endocrine factor in the regulation of the immune 
response (Henson and Castracane, 2003).  Research (Faggioni et al., 1998, 2001) has shown that 
leptin levels are increased by pro-inflammatory cytokines TNF-α and IL-6.  Leptin 
concentrations acutely increase during infection and inflammation, and may represent a 
protective component of the host response to inflammation.  Gainsford et al. (1996) report that 
leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells and 
can enhance the production and phagocytic activity of macrophages.  Faggioni et al. (1999) 
reported that leptin deficiency is accompanied by increased susceptibility to lipopolysaccharide 
(LPS)-induced lethality and decreased induction of anti-inflammatory cytokines, supporting the 
hypothesis that leptin is an important cytokine component of the acute phase response.  From the 
aforementioned research, one may speculate that hypoleptinemia might result in an impaired host 
defense that would increase susceptibility to infection. 
 Understanding the protective role of leptin, with leptin’s ability to influence cytokine 
production, can help in understanding the biological basis for the communication between the 
neuroendocrine system and the immune system.  The focus of the present experiment was to 
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investigate the role and/or regulation of leptin during a low-dose insufion of endotoxin to mares 
and geldings with high vs. low plasma leptin concentrations.  
Materials and Methods 
 
Selection of Horses.  All horses were of light horse breed from the resident herd at the 
Louisiana Agricultural Experiment Station-Central Stations Horse Farm.  The horses were 
routinely maintained on native grass pastures during the spring, summer, and fall, and on 
ryegrass pasture in winter.  Two weeks before to the experiment, the total population of 50 mares 
and geldings was assigned a BCS as described by Henneke et al (1983; 1 = extremely emaciated 
through 9 = extremely fat) by one experienced technician.  Two early morning (before 8:00 a.m.) 
jugular blood samples were collected from each horse during a two week interval into 
heparinized tubes for determination of initial leptin and insulin concentrations.  From the mares 
and geldings with a mean BCS of at least 7.5, 16 horses were selected that had the lowest (low 
leptin; 4 mares and 4 geldings) and highest (high leptin; 4 mares and 4 geldings) leptin 
concentrations.   
Daily Monitoring.  To establish baseline daily concentrations of the various cytokines 
and hormones of interest, samples of jugular blood were collected at 48-hr intervals, beginning 6 
d before the experiment.  The horses were brought from the pasture on each occasion and 
sampled within 1 h or less.  These samples were collected into evacuated, heparinized tubes, and 
the plasma was harvested by centrifugation (1,200 x g for 20 min at 5ºC) and stored at -15ºC.   
Experimental Design.  The experiment was performed as a switch-back with eight mares 
and eight geldings, half of which from each gender were hyperleptinemic (as defined by Cartmill 
et al., 2003) and the rest were normoleptinemic.  Due to restrictions in equipment and facilities, 
the experiment was conducted in two replications of eight horses each, balanced as to gender and 
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leptin status.  The first replicate was initiated on July 28, when half of the horses received 
endotoxin infusion and the other half received vehicle infusion, and reached completion on 
August 1, when the treatments were reversed.  The second replicate was performed between 
August 5 and 11. 
Instrumentation.  On the morning of the infusions, eight horses (2 high leptin mares; 2 
high leptin geldings; 2 low leptin mares; 2 low leptin geldings) were brought in from the pasture 
at 0600, placed in individual stalls, and tethered.  A 14-guage, 13.3-cm Teflon coated catheter 
(BD, Franklin Lakes, NJ)  was inserted into the left jugular vein for collection of blood.  Another 
catheter was inserted into the right jugular vein for infusion of endotoxin or saline solution.  Two 
randomly selected horses were moved from their stall at 0700, placed in individual stocks, and 
cross-tied.  The horses were then prepared for the infusion.  This protocol was repeated each 
hour, until all 8 horses had been infused. 
Hematologic Variables.  Blood samples were collected before endotoxin or saline 
infusion at -60, -30, -20, -10 min. Frequent blood samples were taken after endotoxin or saline 
infusion (t = 0) at 20, 30, 60, 90, 120, 150, 180, 210, 240 min, and 6, 8, 12, 16, 20, and 24 h.  
Blood samples were collected into tubes containing heparin and were centrifuged within 30 min 
and the plasma was stored at -15º C.   
Jugular venous blood was collected into tubes containing EDTA for CBC determination. 
CBC blood samples were taken at t = 0 and 1 and 2 h post-infusion. The tubes were transported, 
on ice, to the LSU School of Veterinary Medicine’s Clinical Pathology Laboratory for 
evaluation. Variables determined were: total white blood counts, segmented neutrophils, 
neutrophil bands, lymphocytes, platelets, packed cell volume, and total protein. 
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Clinical Signs of Disease.  Clinical signs of disease were monitored and recorded during 
the 24-hour time period.  Heart rate (beats per minute), respiratory rate (breaths per minute), 
mucous membrane color, capillary refill time (seconds), rectal temperature (º F), and 
gastrointestinal sounds were monitored and recorded at -60, 0, 1, 2, 3, and 4 h,  then every 2 h 
until 16 h after infusion. 
Blood Analyses. Concentrations of insulin (Diagnostic Systems Laboratory, Webster, 
TX), growth hormone (Thompson et al., 1992) and cortisol (DSL) were determined by 
radioimmunoassay previously validated for horse samples (Cartmill et al., 2003).  Assay 
sensitivities and intra- and inter-assay coefficients of variation were 0.1 ng/mL, 5% and 8% for 
insulin; 0.5 ng/mL, 8% and 11% for GH; and 0.11 μg/dL, 5% and 8 % for cortisol.  
Concentrations of leptin were measured with a double-antibody leptin radioimmunoassay 
procedure described by Cartmill et al. (2003). Estimates of the intra- and inter-assay CV 
averaged 6% and 4%, respectively.  Sensitivity of the leptin assay, based on a 200-μL sample 
size, was 0.1 ng/mL.  Prolactin concentrations were estimated in plasma by radioimmunoassay 
previously validated for horses (Colborn et al., 1991). Intra- and interassay CV and assay 
sensitivity were 7%, 12% and 0.2 ng/mL. 
 Statistical Analyses.  The data was analyzed by ANOVA via the GLM procedure of SAS 
(SAS Institute, Cary, NC).  Main effects of leptin status and gender were factors in the analyses, 
as well as the interaction; these latter effects were tested with a horse (leptin status x gender) 
term.  Endotoxin treatment, day, square and the horse (leptin status x gender) term were analyzed 
in the same ANOVA as replicated (n = 4) 2 x 2 Latin squares, using the 4-way interaction  
(square, treatment, day and horse) term as the error term.  Time (minutes relative to endotoxin 
treatment) and the treatment x time interaction were tested with residual error. 
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Results 
Total Leukocytes.  There was no difference in total leukocyte counts between the high 
leptin group and the low leptin group, or between gender (Figure 5.1).  Endotoxin administration 
resulted in the activation of leukocytes.  Endotoxin-treated horses had fewer total leukocytes (P 
= <.0001) from post-infusion hour 1 through 2.   
Total Lymphocytes.  There were no differences in total lymphocyte counts between the 
high leptin group and the low leptin group.  Mares had a significantly higher (P = 0.0447) 
lymphocyte number as compared to the geldings.  Changes in lymphocyte counts mimicked 
changes in total leukocyte counts.  Endotoxin-treated horses had total lymphocyte numbers 

























Figure 5.1.  Mean total blood leukocyte counts. Endotoxin-treated horses had fewer total 





















Figure 5.2.  Mean total blood lymphocytes counts. Endotoxin-treated horses had fewer total 





Total Neutrophils.  There were no differences in total neutrophils counts between the 
high leptin group and the low leptin group, nor between gender. Neutrophil migration increased 
dramatically during the first hour of LPS exposure.  Endotoxin-treated horses had segmented 
neutrophil numbers decrease significantly (P < 0.0001)  at post-infusion hour 1 through 2 (Figure 
5.3).  No neutrophil bands were observed during this time-frame.  
Platelet Counts.  Endotoxin-treatments had no effect on platelet counts (Figure 5.4), 
although there was a difference in leptin (P = 0.012), gender (P = 0.06), and leptin x gender (P 








































Figure 5.3.  Mean total blood neutrophil counts. Endotoxin-treated horses had segmented 

























Figure 5.4.  Mean total platelet counts. Mean total platelet counts (cells/μl) in horses given a low 





Packed Cell Volume and Total Protein.  Endotoxin-treated horses had  packed cell 
volume (PCV) increase (P <.0001) at hour 1 through hour 24 (Figure 5.5).  Total protein was 
also increased (P = 0.0012) during the 24-hour period (Figure 5.6).  However, there were no 
differences between the high leptin group and the low leptin group, nor between gender.   
With the exception of the platelet counts, changes in all of the hematologic variables 
were observed after  LPS-infusion.  Additionally, with the exception of the platelet counts, there 
was no leptin status effect. (Table 5.1). With the exception of lymphocyte counts, there was no 
gender effect.  Mares had a significantly higher (P = 0.0447) lymphocyte number as compared to 




































Figure 5.5.  Mean packed cell volume. Mean packed cell volume (PCV) in horses given a low 




















Table 5.1  Sources of variation in the ANOVA and associated P-values for each hematologic 































































































































































Clinical Signs of Disease.  Heart rate was increased significantly (P <.0001)  from post-
infusion hour 1 through 8 in endotoxin-treated horses (Figure 5.7).   Respiratory rate also 
increased (P <.0001) in endotoxin-treated horses (Figure 5.8). Temperature accordingly 
increased (P <.0001) in endotoxin-treated horses (Figure 5.9).  Mucous membrane color was not 
consistent among horses; however, all treated horses developed tacky and injected mucous 
membranes during the first few hours after endotoxin infusion.  Capillary refill time increased to 
three seconds on endotoxin-treated horses, compared with the baseline value of <2 seconds.  
Endotoxin-treated horses showed signs of lethargy, transient abdominal pain and mild depression 
from post-infusion hour 0.5 to 8.  With regard to clinical signs of disease, there were no 
















Figure 5.7.  Mean heart rate. Horses were administered an infusion of endotoxin 
(lipopolysaccharide; 35 ng/kg during a 30-minute period) or an equivalent volume of saline 

















































Figure 5.8.  Mean respiratory rate. Horses were administered an infusion of endotoxin 
(lipopolysaccharide; 35 ng/kg during a 30-minute period) or an equivalentvolume of saline 




























Figure 5.9.  Mean rectal temperature. Horses were administered an infusion of endotoxin 
(lipopolysaccharide; 35 ng/kg during a 30-minute period) or an equivalent volume of saline 
(0.9% NaCl) solution during the same time period. 
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Insulin.  Insulin levels were measured two weeks before the start of the experiment.  
Insulin levels were different (P = 0.0026) with regard to leptin status, with high leptin horses 
having higher insulin levels than the low leptin horses (Figure 5.10). 
Cortisol.  The overall mean cortisol level during the 24-hour period was significantly 
different (P = 0.0034) between the endotoxin-treated horses and the saline-infused horses (Figure 
5.11).  Cortisol levels began to rise at one hour post-treatment and remained high until post-
infusion hour 8.  However, there was no leptin or gender effect. 
Growth Hormone.  The overall mean growth hormone (GH) concentrations during the 
24-hour period was significantly differennt (P = 0.0086) between the endotoxin-treated horses 
and the saline-infused horses (Figure 5.12).  Although, endotoxin-treated horses had higher GH 


















Figure 5.10.  Resting concentrations of insulin. Resting concentrations of insulin (mIU/L) in 
































Figure 5.11.  Mean concentrations of cortisol. Concentrations of cortisol (μlU/mL) in horses 





































Figure 5.12.  Mean concentrations of GH. Concentrations of GH (ng/mL) in horses administered 
an infusion of LPS or an equivalent volume of saline solution. 
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Prolactin.  The overall mean prolactin concentration during the 24-hour period was 
significantly differennt (P = 0.0073) between the endotoxin-treated horses and the saline-infused 
horses (Figure 5.13).  Endotoxin-treated horses had higher PRL levels than the control horses, 
but there was no leptin or gender effect. 
Leptin. The overall mean plasma leptin concentrations during the 24-hour period was 
significantly different (P = 0.0076) between the endotoxin-treated horses and the saline-infused 
horses (Figure 5.14).  Endotoxin-treated horses had higher leptin levels than the control horses, 





















Figure 5.13.  Mean concentrations of prolactin. Concentrations of PRL (ng/mL) in horses 






























































Figure 5.14.  Mean concentrations leptin. Concentrations of plasma leptin (ng/mL) in horses 
administered an infusion of LPS or an equivalent volume of saline solution. 
 
                                                 
During the 24-h experiment, all horses receiving the low-dosage of endotoxin had 
significant clinical signs of endotoxemia.  However, there were no differences with regard to 
leptin status or gender. From the results of this experiment, it appears that hyperleptinemia does 
not alter the pro-inflammatory cytokine response after administration of a low-dose of endotoxin 
to healthy, conscious, adult horses (Table 5.2).   
Discussion 
During the experiment an initial leucopenia, neutropenia and lymphopenia were observed 
within 1 to 2 h after LPS infusion.  Experimentally, administration of endotoxin to horses results 
in neutropenia within 90 min with a return to baseline numbers within 6 to 18 h (Reed et al., 
2004).  No neutrophil bands were observed, indicating no release of immature neutrophils from 
the bone marrow.  Lymphopenia is frequently associated with severe systemic stress and acute 
systemic insult. 
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Table 5.2.  Sources of variation in the ANOVA and associated P-values for each 































































































































* Insulin was measured 2 wk before the experiment and not during the endotoxin-
infusion.          
 
            
 
During the first 2 h of the experiment, LPS treatments had no effect on platelet counts, 
although the high leptin horses exhibited higher platelet counts than the low leptin horses.  
Geldings also had higher platelet counts than the mares.  Studies in humans (Nakata, et al., 1998; 
Konstantinides et al., 2001) suggested that platelets express the long form of the leptin receptor, 
and high concentrations of leptin are reported to act synergistically with ADP to promote platelet 
aggregation. Nakata et al. (1999) concluded that a high concentration of leptin has the function 
of promoting platelet aggregation, which may explain why obese people develop dangerous  
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blood clots. A main theory for the pathogenesis of equine acute laminitis involves the 
development of vasoconstriction within the foot, which leads to ischemic and/or inflammatory 
tissue damage (Elliot and Bailey, 2006).  Extremely high platelet counts could lead to 
thrombosis, possibly increasing the risk of equine laminitis or organ dysfunction (Brown and 
Bertone, 2002).   
The PCV and TP of endotoxin-treated horses rose above the baseline at 1 h and continued 
through 24 h of the experiment.  The PCV is a useful monitor of dehydration.  In general terms, a 
PCV greater than 45% indicates a reduction in the fluid fraction of the blood, thereby raising the 
relative level of red blood cells.  Pain, excitement, or other stresses, can increase the PCV 
markedly, but generally does not influence TP.  
With the exception of the platelet counts, all of the changes observed in the hematologic 
variables were significant in regard to LPS-infusion.  Additionally, with the exception of the 
platelet counts, there was no leptin status effect. With the exception of the lymphocyte counts, 
there was no gender effect in the hematologic variables studied. Mares had a significantly higher 
(P = 0.0447) lymphocyte number as compared to the geldings.   
During the 24-h experiment, all horses receiving the low-dosage of endotoxin had 
significant clinical signs of endotoxemia.  However, there were no differences with regard to 
leptin status or gender. Moore and Barton (1998) reported that common clinical effects of 
endotoxemia are increased heart and respiratory rates, alterations in the color of the horse’s 
mucous membranes, prolongation of the capillary refill time, fever, and reduced gastrointestinal 
sounds. Results of the present experiment were consistent with Clark and Moore (1989), which 
reported that all horses in the experiment, having received a slow infusion of a low-dosage of  
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endotoxin, became depressed, displayed injected mucous membranes, and showed increases in 
heart rate, respiratory rate and temperature.  
Plasma insulin concentrations were measured 2 wk before the start of the experiment.  
Insulin levels were significantly different with regard to leptin status, with high leptin horses 
having higher insulin levels than the low leptin horses.  This finding is consistent with Cartmill 
et al. (2003), which showed that obese hyperleptinemic mares and geldings had elevated resting 
insulin concentrations as well as an exaggerated insulin response to glucose infusion.  In a 
number of species, the two factors most often reported to stimulate leptin secretion either in vivo 
(Larsson and Ahren, 1996; Miell et al., 1996; Ramsay and White, 2000) or in vitro (Cammisotto 
and Bukowiecki, 2002) are glucocorticoids and insulin. 
Cortisol, a steroid hormone produced and secreted by the adrenal cortices, is the 
physiological glucocorticoid in horses.  In the present experiment, the overall mean cortisol level 
during the 24-h period was significantly different between the endotoxin-treated horses and the 
saline-infused horses, although there was no leptin status or gender difference. These results are 
conflicting to what was previously observed by Cartmill and co-workers (2003), in that mares 
selected for high leptin had greater cortisol concentrations than mares selected for low leptin, 
with the opposite being true for geldings.   
Toutain et al., (1987) reported that the most typical feature of hydrocortisone profiles in 
horses is a relatively regular decrease in plasma hydrocortisone concentrations during the 
afternoon and the beginning of the dark period.  In the present experiment, no diurnal rhythm in 
total cortisol concentrations was apparent in individual horses or in the group mean.  According 
to Irvine and Alexander (1993) the diurnal rhythm can be disrupted by removing the horse from 
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 its accustomed environment.   The horses in the present experiment were moved from their 
pasture into stalls in a covered barn. 
Overall mean GH levels during the 24-h experiment differed between the LPS-infused 
horses and saline-infused horses; however, there was no leptin status effect nor gender effect.  
This is inconsistent with previous research by Cartmill et al. (2003), who reported that horses 
selected for high leptin had lower concentrations of growth hormone.  Reports in other species 
indicated a negative relationship between leptin and GH concentrations (Spurlock et al., 1998; 
Isozaki et al., 1999; Elimam et al., 2001), perhaps via a direct inhibitory effect of GH on 
adipocytes.  Nevertheless, this negative relationship was not shown in the present experiment. 
In the present experiment, the overall mean prolactin levels during the 24-h period 
differed between endotoxin-treated horses and saline-infused horses; nonetheless, there was no 
leptin status nor gender effect. Recent research concluded that prolactin is a multi-functional 
hormone and is secreted not only by the anterior pituitary gland, but also by many extra-pituitary 
sites, including the immune cells (Ben-Jonathan et al., 1996; Matera et al., 2000; De Bellis et al., 
2005; Malaguarnera et al., 2005).  Chikanza and Grossman (1998) categorized prolactin as a pro-
inflammatory neuropeptide, capable of modulating immune and inflammatory responses.  
Inflammatory cytokines IL-6 and TNF-α are also able to induce release of pituitary prolactin 
(Chikanza and Grossman, 1998; DeBellis et al., 2005).  
In the present experiment, overall mean plasma leptin levels during the 24-h period 
differed between endotoxin-treated horses and saline-infused horses; however, there was no 
gender effect.  This is in contrast to previous reports of Buff et al. (2002), who indicated that 
serum leptin concentrations were greater in stallions and geldings, compared to mares.  Others 
(Cartmill et al., 2003) reported that mares displayed greater average plasma leptin concentrations 
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than geldings.  Nevertheless, the present experiment found no gender effect with regard to leptin 
levels. 
The horses in the present experiment were allowed free access to water, but no feed or 
hay.  This fact would account for the decrease in leptin levels in both the LPS-infused and saline-
infused horses at 5 h into the experiment.  
From the results of this experiment, it appears that hyperleptinemia does not alter the pro-
inflammatory cytokine response after administration of a low-dose of endotoxin to healthy, 
conscious, adult horses.  Despite the fact that all of the horses developed clinical signs and 
showed hematologic changes associated with an acute phase response,  leptin status had no effect 
on the production of TNF-α or IL-6.  The results do not exclude an effect of leptin on the 
immune response, but they suggest that obese, hyperleptinemic horses respond the same as obese 
normoleptinemic horses to a low-dose of endotoxin.   
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CHAPTER 6 
SUMMARY AND CONCLUSIONS 
 The goal of the research herein was to investigate the physiologic and genetic differences 
between obese hyperleptinemic horses and obese normoleptinemic horses.  Distinct differences 
in leptin secretion rates do persist in a percentage of obese mares; therefore, three experiments 
were designed and performed to study and possibly provide an explanation as to the cause. 
  The first study concluded that the occurrence of pregnancy was shown to be equally 
likely between hyperleptinemic mares and normoleptinemic mares.  Leptin levels in lactating 
mares were reported to be generally lower than leptin levels in non-lactating mares, which is 
consistent with other research.  It may be hypothesized that a specific and narrow range of leptin 
concentrations is necessary to maintain a normal reproductive function, and that concentrations 
below or above these thresholds might interfere in opposing ways with the function of the 
hypothalamic-pituitary-gonadal axis.  However, to assign a global threshold number for 
infertility would be unrealistic. The high and low boundaries would likely be on an individual 
basis, due to the complex interaction with other molecules such as hormones, growth factors, and 
cytokines.  
The second experiment explored the possibility of a polymorphism within exon 2 of the 
equine leptin gene.  No polymorphism within exon 2 was observed between mares that were  
high vs. low secretors of leptin; therefore, polymorphism is not a likely explanation for the high 
vs. low difference.  Single gene polymorphisms resulting in obesity are very rare, thus the 
conclusion appears more likely that a combination of polymorphisms in one or more candidate 
genes may contribute to the development of obesity.   
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The objective of the third experiment was to further consider the high leptin versus low 
leptin condition, and the interaction of leptin secretion between the endocrine and immune 
systems.  Although there were significant differences between the endotoxin-infused group and 
the saline-infused group of horses, with the exception of the platelet counts, there were no 
significant differences between the obese hyperleptinemic group and the obese normoleptinemic 
group of horses or between mares or geldings.  
Distinct differences in leptin secretion rates do indeed persist in a percentage of obese 
mares, and as reported previously, these differences are associated with perturbations in insulin, 
glucose, and thyroid hormone concentrations.  Because of the complex interactions among leptin 
and other molecules such as hormones, growth factors, and cytokines, future studies should again 
consider possible interactions with other body systems that regulate obesity.  The pathogenesis of 
obesity is complex and interactions between the large number of both genetic and environmental 
factors must be considered.  The knowledge of the interactions among these factors will further 
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